| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.69 | 0.003 | 0.69 | GABA C receptor rho-3 antagonist | 0.565 0.012 DB02362 0.556 0.014 DBMET03291 0.497 0.027 DBMET03292 0.382 0.07 DBMET03290 | ||
| 0.634 | 0.004 | 0.634 | Anesthetic general | 0.492 0.008 DB02362 0.488 0.009 DBMET03291 0.281 0.038 DBMET03292 0.367 0.021 DBMET03290 | ||
| 0.611 | 0.005 | 0.611 | Calcium channel L-type activator | 0.529 0.018 DB02362 0.573 0.009 DBMET03291 0.528 0.018 DBMET03292 0.475 0.038 DBMET03290 | ||
| 0.62 | 0.016 | 0.62 | Cholesterol antagonist | 0.589 0.02 DB02362 0.517 0.03 DBMET03291 0.377 0.055 DBMET03292 0.502 0.032 DBMET03290 | ||
| 0.603 | 0.004 | 0.64 | Peroxidase inhibitor | 0.64 0.004 DB02362 0.44 0.015 DBMET03291 0.535 0.007 DBMET03292 0.48 0.011 DBMET03290 | DB02362 | |
| 0.573 | 0.013 | 0.686 | Histamine release inhibitor | 0.612 0.009 DB02362 0.638 0.007 DBMET03291 0.401 0.075 DBMET03292 0.686 0.005 DBMET03290 | DBMET03290 | |
| 0.551 | 0.004 | 0.551 | Anesthetic local | 0.254 0.019 DB02362 0.388 0.007 DBMET03291 0.152 0.048 DBMET03292 0.187 0.036 DBMET03290 | ||
| 0.553 | 0.025 | 0.726 | Aldehyde oxidase inhibitor | 0.726 0.006 DB02362 0.207 0.101 DBMET03291 0.219 0.095 DBMET03292 0.512 0.031 DBMET03290 | DB02362 | |
| 0.522 | 0.004 | 0.868 | Alcohol oxidase inhibitor | 0.868 0.002 DB02362 0.312 0.004 DBMET03291 0.185 0.007 DBMET03292 0.82 0.003 DBMET03290 | DB02362 | |
| 0.496 | 0.005 | 0.496 | Calcium channel activator | 0.384 0.031 DB02362 0.409 0.022 DBMET03291 0.403 0.023 DBMET03292 0.285 0.107 DBMET03290 | ||
| 0.515 | 0.028 | 0.679 | 5 Hydroxytryptamine release inhibitor | 0.608 0.01 DB02362 0.573 0.015 DBMET03291 0.377 0.093 DBMET03292 0.679 0.005 DBMET03290 | DBMET03290 | |
| 0.521 | 0.036 | 0.521 | 15-Lipoxygenase inhibitor | 0.36 0.094 DB02362 0.421 0.065 DBMET03291 0.21 0.202 DBMET03292 0.266 0.152 DBMET03290 | ||
| 0.459 | 0.004 | 0.551 | Carbonic anhydrase XV inhibitor | 0.551 0.003 DB02362 0.328 0.006 DBMET03291 0.137 0.036 DBMET03292 0.369 0.005 DBMET03290 | DB02362 | |
| 0.463 | 0.012 | 0.524 | Interleukin agonist | 0.48 0.01 DB02362 0.493 0.009 DBMET03291 0.236 0.09 DBMET03292 0.524 0.007 DBMET03290 | DBMET03290 | |
| 0.459 | 0.022 | 0.459 | Vasodilator, coronary | 0.32 0.072 DB02362 0.377 0.043 DBMET03291 0.309 0.081 DBMET03292 0.266 0.119 DBMET03290 | ||
| 0.432 | 0.006 | 0.447 | Lipocortins synthesis antagonist | 0.447 0.005 DB02362 0.248 0.034 DBMET03291 0.304 0.02 DBMET03292 0.242 0.036 DBMET03290 | DB02362 | |
| 0.439 | 0.016 | 0.462 | Sigma receptor agonist | 0.462 0.014 DB02362 0.17 0.073 DBMET03291 0.157 0.081 DBMET03290 | DB02362 | |
| 0.429 | 0.008 | 0.887 | Alpha-N-acetylglucosaminidase inhibitor | 0.75 0.003 DB02362 0.682 0.003 DBMET03291 0.333 0.013 DBMET03292 0.887 0.001 DBMET03290 | DBMET03290 | |
| 0.458 | 0.051 | 0.458 | Transcription factor NF kappa B inhibitor | 0.384 0.067 DB02362 0.358 0.074 DBMET03291 0.189 0.181 DBMET03292 0.296 0.097 DBMET03290 | ||
| 0.407 | 0.003 | 0.407 | GABA C receptor rho-2 antagonist | 0.26 0.01 DB02362 0.255 0.011 DBMET03291 0.22 0.02 DBMET03292 0.17 0.051 DBMET03290 | ||
| 0.439 | 0.044 | 0.499 | Vasodilator, peripheral | 0.363 0.069 DB02362 0.499 0.028 DBMET03291 0.243 0.133 DBMET03292 0.449 0.041 DBMET03290 | DBMET03291 | |
| 0.4 | 0.027 | 0.625 | Superoxide dismutase inhibitor | 0.625 0.006 DB02362 0.249 0.075 DBMET03291 0.19 0.129 DBMET03292 0.438 0.02 DBMET03290 | DB02362 | |
| 0.399 | 0.038 | 0.41 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.41 0.036 DB02362 0.392 0.04 DBMET03291 0.396 0.039 DBMET03290 | DB02362 | |
| 0.39 | 0.039 | 0.39 | Aryl hydrocarbon receptor agonist | 0.375 0.042 DB02362 0.377 0.042 DBMET03291 0.35 0.048 DBMET03290 | ||
| 0.384 | 0.044 | 0.384 | Spasmolytic | 0.232 0.099 DB02362 0.277 0.08 DBMET03291 0.174 0.142 DBMET03292 0.167 0.148 DBMET03290 | ||
| 0.382 | 0.05 | 0.382 | 5 Hydroxytryptamine release stimulant | 0.296 0.071 DB02362 | ||
| 0.399 | 0.067 | 0.399 | Prostaglandin dehydrogenase inhibitor | 0.259 0.122 DB02362 0.295 0.104 DBMET03291 | ||
| 0.351 | 0.025 | 0.351 | Cyclic AMP phosphodiesterase inhibitor | 0.314 0.036 DB02362 0.283 0.049 DBMET03291 0.165 0.129 DBMET03292 0.252 0.063 DBMET03290 | ||
| 0.327 | 0.007 | 0.434 | Succinate dehydrogenase inhibitor | 0.434 0.004 DB02362 0.282 0.014 DBMET03291 0.26 0.019 DBMET03292 0.373 0.005 DBMET03290 | DB02362 | |
| 0.326 | 0.009 | 0.421 | UDP-glucose 4-epimerase inhibitor | 0.402 0.005 DB02362 0.353 0.008 DBMET03291 0.3 0.01 DBMET03292 0.421 0.005 DBMET03290 | DBMET03290 | |
| 0.341 | 0.025 | 0.352 | RNA-directed DNA polymerase inhibitor | 0.352 0.024 DB02362 0.216 0.078 DBMET03291 0.176 0.139 DBMET03292 0.222 0.072 DBMET03290 | DB02362 | |
| 0.42 | 0.108 | 0.56 | DNA directed DNA polymerase inhibitor | 0.305 0.159 DB02362 0.56 0.066 DBMET03291 0.25 0.191 DBMET03292 0.435 0.102 DBMET03290 | DBMET03291 | |
| 0.331 | 0.021 | 0.331 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 DB02362 0.27 0.051 DBMET03291 0.317 0.026 DBMET03292 0.279 0.045 DBMET03290 | ||
| 0.308 | 0.004 | 0.342 | GABA C receptor antagonist | 0.342 0.004 DB02362 0.147 0.032 DBMET03291 0.214 0.01 DBMET03292 0.164 0.023 DBMET03290 | DB02362 | |
| 0.415 | 0.113 | 0.582 | DNA polymerase beta inhibitor | 0.289 0.171 DB02362 0.582 0.063 DBMET03291 0.446 0.102 DBMET03290 | DBMET03291 | |
| 0.375 | 0.074 | 0.496 | Calpain 2 inhibitor | 0.201 0.186 DB02362 0.496 0.025 DBMET03291 0.382 0.071 DBMET03290 | DBMET03291 | |
| 0.302 | 0.007 | 0.377 | Adenylate kinase inhibitor | 0.377 0.004 DB02362 0.165 0.022 DBMET03291 0.2 0.015 DBMET03292 0.256 0.009 DBMET03290 | DB02362 | |
| 0.397 | 0.103 | 0.553 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.523 0.024 DB02362 0.429 0.077 DBMET03291 0.286 0.233 DBMET03292 0.553 0.015 DBMET03290 | DBMET03290 | |
| 0.297 | 0.004 | 0.315 | GABA C receptor rho-1 antagonist | 0.315 0.003 DB02362 0.16 0.018 DBMET03291 0.14 0.026 DBMET03292 0.171 0.014 DBMET03290 | DB02362 | |
| 0.341 | 0.05 | 0.445 | Interleukin 2 agonist | 0.441 0.017 DB02362 0.367 0.039 DBMET03291 0.445 0.017 DBMET03290 | DBMET03290 | |
| 0.305 | 0.016 | 0.305 | Amyloid beta precursor protein antagonist | 0.301 0.017 DB02362 0.257 0.03 DBMET03291 0.233 0.039 DBMET03290 | ||
| 0.31 | 0.021 | 0.383 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.383 0.009 DB02362 0.262 0.037 DBMET03291 0.178 0.096 DBMET03292 0.334 0.015 DBMET03290 | DB02362 | |
| 0.322 | 0.037 | 0.426 | DNA synthesis inhibitor | 0.426 0.019 DB02362 0.213 0.105 DBMET03291 0.173 0.163 DBMET03292 0.306 0.042 DBMET03290 | DB02362 | |
| 0.284 | 0.007 | 0.457 | Histidine decarboxylase inhibitor | 0.457 0.003 DB02362 0.132 0.023 DBMET03291 0.083 0.04 DBMET03292 0.291 0.007 DBMET03290 | DB02362 | |
| 0.295 | 0.019 | 0.479 | Phospholipase C inhibitor | 0.479 0.007 DB02362 0.179 0.062 DBMET03291 0.153 0.101 DBMET03292 0.267 0.022 DBMET03290 | DB02362 | |
| 0.274 | 0.004 | 0.274 | Glutamate release inhibitor | 0.197 0.005 DB02362 0.109 0.031 DBMET03291 0.093 0.055 DBMET03292 0.089 0.064 DBMET03290 | ||
| 0.279 | 0.01 | 0.596 | Ferrochelatase inhibitor | 0.554 0.002 DB02362 0.301 0.007 DBMET03291 0.16 0.034 DBMET03292 0.596 0.002 DBMET03290 | DBMET03290 | |
| 0.274 | 0.007 | 0.382 | Carbonic anhydrase VI inhibitor | 0.382 0.004 DB02362 0.149 0.021 DBMET03291 0.091 0.045 DBMET03292 0.207 0.012 DBMET03290 | DB02362 | |
| 0.268 | 0.009 | 0.269 | Mannose-6-phosphate isomerase inhibitor | 0.269 0.009 DB02362 0.185 0.039 DBMET03291 0.2 0.03 DBMET03292 0.178 0.043 DBMET03290 | DB02362 | |
| 0.382 | 0.123 | 0.493 | Alpha-glucosidase inhibitor | 0.249 0.188 DB02362 0.493 0.082 DBMET03291 0.354 0.134 DBMET03290 | DBMET03291 | |
| 0.301 | 0.048 | 0.301 | Vasodilator | 0.235 0.078 DBMET03291 | ||
| 0.282 | 0.033 | 0.317 | DNA methyltransferase I inhibitor | 0.317 0.021 DB02362 0.284 0.033 DBMET03291 0.176 0.082 DBMET03292 0.31 0.023 DBMET03290 | DB02362 | |
| 0.255 | 0.008 | 0.32 | Carbonic anhydrase XIII inhibitor | 0.32 0.005 DB02362 0.16 0.02 DBMET03291 0.081 0.049 DBMET03292 0.205 0.013 DBMET03290 | DB02362 | |
| 0.288 | 0.042 | 0.349 | Gastrin inhibitor | 0.317 0.023 DB02362 0.318 0.022 DBMET03291 0.24 0.092 DBMET03292 0.349 0.011 DBMET03290 | DBMET03290 | |
| 0.268 | 0.024 | 0.296 | Amylase inhibitor | 0.296 0.019 DB02362 0.132 0.074 DBMET03291 0.153 0.063 DBMET03290 | DB02362 | |
| 0.292 | 0.049 | 0.454 | 5 Hydroxytryptamine uptake stimulant | 0.454 0.007 DB02362 0.219 0.118 DBMET03291 0.197 0.158 DBMET03292 0.373 0.02 DBMET03290 | DB02362 | |
| 0.264 | 0.022 | 0.337 | 3C-like protease (Human coronavirus) inhibitor | 0.251 0.027 DB02362 0.337 0.006 DBMET03291 0.316 0.008 DBMET03290 | DBMET03291 | |
| 0.246 | 0.004 | 0.246 | Toll-Like receptor 3 antagonist | 0.154 0.013 DB02362 0.098 0.053 DBMET03291 | ||
| 0.24 | 0.002 | 0.24 | Granulocyte macrophage colony stimulating factor agonist | 0.143 0.006 DB02362 0.159 0.004 DBMET03291 0.152 0.005 DBMET03292 0.098 0.038 DBMET03290 | ||
| 0.272 | 0.035 | 0.284 | Non-steroidal antiinflammatory agent | 0.284 0.032 DB02362 0.207 0.066 DBMET03291 0.194 0.076 DBMET03292 0.221 0.057 DBMET03290 | DB02362 | |
| 0.31 | 0.074 | 0.31 | 12-Lipoxygenase inhibitor | 0.269 0.099 DB02362 0.3 0.08 DBMET03291 0.219 0.131 DBMET03292 0.257 0.105 DBMET03290 | ||
| 0.284 | 0.047 | 0.284 | Psychostimulant | 0.229 0.067 DB02362 0.136 0.13 DBMET03291 | ||
| 0.245 | 0.009 | 0.351 | Cyclooxygenase 3 inhibitor | 0.235 0.01 DB02362 0.345 0.005 DBMET03291 0.143 0.055 DBMET03292 0.351 0.005 DBMET03290 | DBMET03290 | |
| 0.294 | 0.062 | 0.375 | Insulysin inhibitor | 0.356 0.032 DB02362 0.327 0.043 DBMET03291 0.289 0.066 DBMET03292 0.375 0.027 DBMET03290 | DBMET03290 | |
| 0.276 | 0.047 | 0.276 | Anticonvulsant | 0.192 0.088 DB02362 0.142 0.139 DBMET03291 | ||
| 0.308 | 0.083 | 0.348 | Antithrombotic | 0.328 0.073 DB02362 0.32 0.076 DBMET03291 0.206 0.17 DBMET03292 0.348 0.065 DBMET03290 | DBMET03290 | |
| 0.254 | 0.03 | 0.258 | Nitric-oxide synthase stimulant | 0.258 0.027 DB02362 0.218 0.062 DBMET03291 0.175 0.139 DBMET03292 0.222 0.057 DBMET03290 | DB02362 | |
| 0.241 | 0.019 | 0.3 | Aldehyde dehydrogenase inhibitor | 0.3 0.012 DB02362 0.118 0.073 DBMET03291 0.136 0.056 DBMET03292 0.161 0.041 DBMET03290 | DB02362 | |
| 0.294 | 0.074 | 0.294 | Lipoxygenase inhibitor | 0.235 0.11 DB02362 0.228 0.116 DBMET03291 0.288 0.077 DBMET03292 0.186 0.156 DBMET03290 | ||
| 0.224 | 0.004 | 0.626 | GABA aminotransferase inhibitor | 0.626 0.002 DB02362 0.104 0.024 DBMET03291 0.083 0.043 DBMET03292 0.2 0.004 DBMET03290 | DB02362 | |
| 0.253 | 0.033 | 0.255 | Insulin sensitizer | 0.255 0.032 DB02362 0.237 0.042 DBMET03291 0.153 0.128 DBMET03292 0.244 0.038 DBMET03290 | DB02362 | |
| 0.239 | 0.025 | 0.239 | Interleukin 6 antagonist | 0.215 0.033 DB02362 | ||
| 0.214 | 0.003 | 0.214 | Glutamate (mGluR6) antagonist | 0.189 0.003 DB02362 0.121 0.005 DBMET03291 0.114 0.006 DBMET03292 0.114 0.006 DBMET03290 | ||
| 0.225 | 0.018 | 0.272 | Catenin beta inhibitor | 0.272 0.008 DB02362 0.193 0.038 DBMET03291 0.145 0.118 DBMET03292 0.213 0.023 DBMET03290 | DB02362 | |
| 0.218 | 0.011 | 0.218 | Calcium antagonist | 0.156 0.021 DBMET03291 0.108 0.042 DBMET03292 | ||
| 0.252 | 0.047 | 0.301 | DNA methylase inhibitor | 0.301 0.027 DB02362 0.245 0.051 DBMET03291 0.151 0.117 DBMET03292 0.28 0.034 DBMET03290 | DB02362 | |
| 0.239 | 0.034 | 0.239 | Tumour necrosis factor antagonist | 0.179 0.068 DB02362 0.135 0.12 DBMET03291 0.182 0.065 DBMET03292 | ||
| 0.207 | 0.005 | 0.235 | Acyl-CoA dehydrogenase inhibitor | 0.235 0.004 DB02362 0.141 0.01 DBMET03291 0.11 0.014 DBMET03292 0.191 0.006 DBMET03290 | DB02362 | |
| 0.209 | 0.008 | 0.25 | Keratolytic | 0.25 0.005 DB02362 0.177 0.011 DBMET03291 0.165 0.012 DBMET03292 0.222 0.007 DBMET03290 | DB02362 | |
| 0.222 | 0.025 | 0.384 | Hexokinase inhibitor | 0.362 0.005 DB02362 0.25 0.017 DBMET03291 0.384 0.005 DBMET03290 | DBMET03290 | |
| 0.202 | 0.005 | 0.202 | Ornithine decarboxylase inhibitor | 0.164 0.008 DB02362 0.14 0.014 DBMET03291 0.138 0.015 DBMET03292 0.127 0.021 DBMET03290 | ||
| 0.279 | 0.085 | 0.354 | Immunostimulant | 0.293 0.08 DB02362 0.287 0.082 DBMET03291 0.354 0.063 DBMET03292 0.314 0.075 DBMET03290 | DBMET03292 | |
| 0.265 | 0.073 | 0.265 | DNA damaging | 0.235 0.09 DB02362 0.191 0.124 DBMET03291 | ||
| 0.249 | 0.058 | 0.284 | Neuropeptide Y2 antagonist | 0.227 0.081 DB02362 0.284 0.027 DBMET03291 0.274 0.035 DBMET03290 | DBMET03291 | |
| 0.33 | 0.139 | 0.463 | Transcription factor inhibitor | 0.463 0.086 DBMET03291 0.293 0.159 DBMET03292 0.318 0.145 DBMET03290 | DBMET03291 | |
| 0.246 | 0.056 | 0.286 | MAP kinase kinase 2 inhibitor | 0.286 0.04 DB02362 0.158 0.114 DBMET03291 0.184 0.092 DBMET03290 | DB02362 | |
| 0.214 | 0.025 | 0.214 | Calcium channel blocker | 0.173 0.043 DBMET03291 | ||
| 0.204 | 0.015 | 0.39 | Carbonic anhydrase III inhibitor | 0.39 0.004 DB02362 0.175 0.021 DBMET03291 0.109 0.053 DBMET03292 0.323 0.005 DBMET03290 | DB02362 | |
| 0.2 | 0.013 | 0.2 | Photosensitizer | 0.161 0.025 DB02362 0.158 0.027 DBMET03291 0.139 0.039 DBMET03292 0.131 0.045 DBMET03290 | ||
| 0.233 | 0.049 | 0.275 | Neurotrophic factor enhancer | 0.275 0.026 DB02362 0.148 0.141 DBMET03291 0.198 0.078 DBMET03290 | DB02362 | |
| 0.22 | 0.037 | 0.251 | Diuretic | 0.251 0.03 DB02362 0.185 0.051 DBMET03291 0.213 0.039 DBMET03290 | DB02362 | |
| 0.208 | 0.026 | 0.214 | Arachidonic acid antagonist | 0.214 0.021 DB02362 0.165 0.071 DBMET03291 0.163 0.074 DBMET03292 0.179 0.055 DBMET03290 | DB02362 | |
| 0.31 | 0.128 | 0.461 | Antibacterial | 0.461 0.053 DB02362 0.22 0.207 DBMET03291 0.216 0.211 DBMET03292 0.382 0.085 DBMET03290 | DB02362 | |
| 0.184 | 0.003 | 0.205 | Dihydropteroate synthase inhibitor | 0.205 0.002 DB02362 0.145 0.004 DBMET03291 0.04 0.026 DBMET03292 0.154 0.003 DBMET03290 | DB02362 | |
| 0.192 | 0.011 | 0.462 | NADH dehydrogenase inhibitor | 0.462 0.004 DB02362 0.112 0.034 DBMET03291 0.111 0.034 DBMET03292 0.235 0.008 DBMET03290 | DB02362 | |
| 0.2 | 0.02 | 0.706 | GABA C receptor agonist | 0.706 0.002 DB02362 0.095 0.073 DBMET03291 0.094 0.074 DBMET03292 0.4 0.005 DBMET03290 | DB02362 | |
| 0.202 | 0.023 | 0.233 | Toll-Like receptor 2 antagonist | 0.155 0.049 DB02362 0.233 0.012 DBMET03291 0.141 0.059 DBMET03292 0.195 0.026 DBMET03290 | DBMET03291 | |
| 0.191 | 0.012 | 0.445 | Triose-phosphate isomerase inhibitor | 0.445 0.003 DB02362 0.15 0.02 DBMET03291 0.233 0.008 DBMET03292 0.355 0.004 DBMET03290 | DB02362 | |
| 0.183 | 0.007 | 0.41 | Biliverdin reductase inhibitor | 0.41 0.002 DB02362 0.112 0.015 DBMET03291 0.09 0.022 DBMET03292 0.309 0.003 DBMET03290 | DB02362 | |
| 0.192 | 0.016 | 0.229 | Mediator release inhibitor | 0.162 0.024 DB02362 0.229 0.011 DBMET03291 0.179 0.019 DBMET03292 0.196 0.015 DBMET03290 | DBMET03291 | |
| 0.191 | 0.017 | 0.306 | Catalase inhibitor | 0.213 0.013 DB02362 0.256 0.008 DBMET03291 0.097 0.039 DBMET03292 0.306 0.006 DBMET03290 | DBMET03290 | |
| 0.276 | 0.103 | 0.316 | Apoptosis antagonist | 0.316 0.075 DB02362 0.246 0.132 DBMET03291 0.276 0.103 DBMET03290 | DB02362 | |
| 0.212 | 0.042 | 0.273 | Cytidine deaminase inhibitor | 0.189 0.053 DB02362 0.273 0.024 DBMET03291 0.252 0.029 DBMET03290 | DBMET03291 | |
| 0.177 | 0.008 | 0.201 | Ca2+-transporting ATPase inhibitor | 0.201 0.003 DB02362 0.154 0.035 DBMET03291 0.158 0.027 DBMET03292 0.176 0.009 DBMET03290 | DB02362 | |
| 0.179 | 0.012 | 0.188 | Heat shock protein 70 antagonist | 0.188 0.009 DB02362 0.179 0.012 DBMET03291 0.135 0.094 DBMET03292 0.186 0.009 DBMET03290 | DB02362 | |
| 0.301 | 0.134 | 0.551 | Beta lactamase inhibitor | 0.551 0.064 DBMET03291 0.293 0.137 DBMET03290 | DBMET03291 | |
| 0.227 | 0.061 | 0.268 | MAP kinase kinase 3 inhibitor | 0.268 0.018 DB02362 | DB02362 | |
| 0.204 | 0.04 | 0.24 | Phospholipase A2 inhibitor | 0.24 0.026 DB02362 0.185 0.051 DBMET03291 0.124 0.11 DBMET03292 0.228 0.03 DBMET03290 | DB02362 | |
| 0.197 | 0.034 | 0.283 | M17 leucyl aminopeptidase inhibitor | 0.24 0.022 DB02362 0.259 0.019 DBMET03291 0.177 0.042 DBMET03292 0.283 0.014 DBMET03290 | DBMET03290 | |
| 0.213 | 0.051 | 0.236 | Histone acetyltransferase inhibitor | 0.236 0.032 DB02362 0.149 0.142 DBMET03291 0.178 0.102 DBMET03290 | DB02362 | |
| 0.186 | 0.025 | 0.186 | Nav1.6 sodium channel blocker | 0.122 0.092 DB02362 0.115 0.104 DBMET03291 | ||
| 0.174 | 0.012 | 0.422 | Glutamate dehydrogenase inhibitor | 0.422 0.004 DB02362 0.119 0.023 DBMET03291 0.094 0.034 DBMET03292 0.265 0.007 DBMET03290 | DB02362 | |
| 0.276 | 0.117 | 0.352 | Thioredoxin glutathione reductase inhibitor | 0.352 0.076 DBMET03291 0.234 0.146 DBMET03290 | DBMET03291 | |
| 0.178 | 0.019 | 0.228 | Mucolytic | 0.202 0.013 DB02362 0.193 0.015 DBMET03291 0.094 0.087 DBMET03292 0.228 0.009 DBMET03290 | DBMET03290 | |
| 0.184 | 0.027 | 0.184 | Neuropeptide Y1 antagonist | 0.153 0.06 DB02362 0.178 0.031 DBMET03291 0.146 0.071 DBMET03290 | ||
| 0.268 | 0.112 | 0.445 | Thyroid hormone antagonist | 0.445 0.044 DBMET03291 0.268 0.112 DBMET03290 | DBMET03291 | |
| 0.181 | 0.025 | 0.224 | Expectorant | 0.218 0.017 DB02362 0.178 0.026 DBMET03291 0.224 0.016 DBMET03290 | DBMET03290 | |
| 0.213 | 0.057 | 0.225 | LIM domain kinase 1 inhibitor | 0.225 0.051 DB02362 0.162 0.086 DBMET03291 0.168 0.082 DBMET03290 | DB02362 | |
| 0.318 | 0.162 | 0.334 | MAP kinase 1 inhibitor | 0.334 0.147 DBMET03291 | DBMET03291 | |
| 0.237 | 0.085 | 0.258 | Hypoglycemic | 0.258 0.072 DB02362 0.163 0.157 DBMET03291 0.174 0.142 DBMET03290 | DB02362 | |
| 0.212 | 0.06 | 0.212 | Focal adhesion kinase 2 inhibitor | 0.194 0.074 DB02362 0.178 0.089 DBMET03291 0.16 0.114 DBMET03290 | ||
| 0.165 | 0.014 | 0.165 | Toll-Like receptor 4 antagonist | 0.109 0.057 DB02362 0.153 0.02 DBMET03291 0.12 0.044 DBMET03292 0.097 0.075 DBMET03290 | ||
| 0.16 | 0.01 | 0.343 | Phenylalanine 4-hydroxylase inhibitor | 0.343 0.004 DB02362 0.094 0.028 DBMET03291 0.144 0.013 DBMET03292 0.193 0.007 DBMET03290 | DB02362 | |
| 0.176 | 0.027 | 0.243 | Sphingosine 1-phosphate receptor 5 antagonist | 0.203 0.01 DB02362 0.208 0.009 DBMET03291 0.122 0.121 DBMET03292 0.243 0.004 DBMET03290 | DBMET03290 | |
| 0.152 | 0.004 | 0.351 | Aconitate hydratase inhibitor | 0.351 0.002 DB02362 0.082 0.013 DBMET03291 0.098 0.009 DBMET03292 0.152 0.004 DBMET03290 | DB02362 | |
| 0.218 | 0.072 | 0.218 | ErbB-1 antagonist | 0.204 0.084 DB02362 | ||
| 0.175 | 0.03 | 0.185 | Adenylate cyclase stimulant | 0.185 0.022 DB02362 0.129 0.104 DBMET03292 0.129 0.104 DBMET03290 | DB02362 | |
| 0.184 | 0.04 | 0.184 | Interleukin 1 antagonist | 0.15 0.057 DB02362 0.124 0.083 DBMET03291 | ||
| 0.148 | 0.004 | 0.223 | NMDA receptor glycine site agonist | 0.185 0.003 DB02362 0.18 0.003 DBMET03291 0.113 0.011 DBMET03292 0.223 0.003 DBMET03290 | DBMET03290 | |
| 0.189 | 0.047 | 0.189 | Acetylcholine M1 receptor antagonist | 0.137 0.088 DB02362 0.132 0.093 DBMET03291 | ||
| 0.171 | 0.03 | 0.241 | Aminopeptidase B inhibitor | 0.241 0.014 DB02362 0.136 0.044 DBMET03291 0.176 0.028 DBMET03292 0.209 0.019 DBMET03290 | DB02362 | |
| 0.188 | 0.046 | 0.218 | Protein kinase stimulant | 0.218 0.036 DB02362 0.155 0.065 DBMET03291 0.169 0.056 DBMET03292 0.186 0.047 DBMET03290 | DB02362 | |
| 0.164 | 0.023 | 0.321 | Potassium channel (Ca-activated) activator | 0.321 0.005 DB02362 0.173 0.021 DBMET03290 | DB02362 | |
| 0.178 | 0.039 | 0.178 | Toll-Like receptor antagonist | |||
| 0.147 | 0.008 | 0.302 | NMDA receptor agonist | 0.266 0.004 DB02362 0.176 0.005 DBMET03291 0.092 0.022 DBMET03292 0.302 0.003 DBMET03290 | DBMET03290 | |
| 0.152 | 0.015 | 0.152 | Acetylcholine release stimulant | 0.126 0.039 DB02362 0.114 0.058 DBMET03291 | ||
| 0.175 | 0.039 | 0.241 | Monophenol monooxygenase inhibitor | 0.241 0.025 DB02362 0.132 0.055 DBMET03291 0.107 0.071 DBMET03292 0.196 0.034 DBMET03290 | DB02362 | |
| 0.252 | 0.117 | 0.436 | Thyroid hormone beta antagonist | 0.436 0.044 DBMET03291 0.253 0.117 DBMET03290 | DBMET03291 | |
| 0.22 | 0.085 | 0.281 | Angiogenesis stimulant | 0.281 0.056 DB02362 0.187 0.101 DBMET03290 | DB02362 | |
| 0.154 | 0.02 | 0.635 | Porphobilinogen synthase inhibitor | 0.635 0.003 DB02362 0.089 0.042 DBMET03291 0.075 0.051 DBMET03292 0.471 0.004 DBMET03290 | DB02362 | |
| 0.138 | 0.005 | 0.16 | Carbonic anhydrase XIV inhibitor | 0.16 0.005 DB02362 0.115 0.008 DBMET03291 0.043 0.042 DBMET03292 0.121 0.007 DBMET03290 | DB02362 | |
| 0.18 | 0.048 | 0.181 | Thiol protease inhibitor | 0.159 0.062 DB02362 0.181 0.048 DBMET03291 0.162 0.059 DBMET03290 | DBMET03291 | |
| 0.145 | 0.013 | 0.145 | Lanosterol 14 alpha demethylase inhibitor | 0.132 0.02 DB02362 0.106 0.047 DBMET03291 0.093 0.067 DBMET03290 | ||
| 0.176 | 0.045 | 0.183 | Cytokine production inhibitor | 0.183 0.042 DBMET03291 0.109 0.101 DBMET03290 | DBMET03291 | |
| 0.154 | 0.024 | 0.31 | HIV-1 integrase (Overall Integration) inhibitor | 0.31 0.003 DB02362 0.179 0.016 DBMET03290 | DB02362 | |
| 0.2 | 0.071 | 0.301 | I kappa B kinase epsilon inhibitor | 0.301 0.015 DB02362 0.231 0.048 DBMET03290 | DB02362 | |
| 0.165 | 0.036 | 0.234 | Cathepsin H inhibitor | 0.234 0.015 DB02362 0.116 0.08 DBMET03291 0.186 0.027 DBMET03290 | DB02362 | |
| 0.155 | 0.029 | 0.195 | Sphingosine 1-phosphate receptor 4 antagonist | 0.154 0.029 DB02362 0.19 0.011 DBMET03291 0.195 0.01 DBMET03290 | DBMET03290 | |
| 0.152 | 0.026 | 0.469 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.414 0.004 DB02362 0.205 0.015 DBMET03291 0.091 0.064 DBMET03292 0.469 0.003 DBMET03290 | DBMET03290 | |
| 0.146 | 0.02 | 0.18 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.18 0.012 DB02362 0.087 0.046 DBMET03291 0.114 0.031 DBMET03290 | DB02362 | |
| 0.157 | 0.032 | 0.206 | Sphingosine 1-phosphate receptor 2 antagonist | 0.166 0.024 DB02362 0.188 0.011 DBMET03291 0.117 0.106 DBMET03292 0.206 0.006 DBMET03290 | DBMET03290 | |
| 0.204 | 0.079 | 0.265 | Pyruvate kinase inhibitor | 0.265 0.057 DB02362 0.162 0.106 DBMET03291 0.208 0.077 DBMET03292 0.2 0.081 DBMET03290 | DB02362 | |
| 0.153 | 0.029 | 0.159 | TRPA1 agonist | 0.147 0.033 DB02362 0.158 0.026 DBMET03291 0.118 0.061 DBMET03292 0.159 0.025 DBMET03290 | DBMET03290 | |
| 0.195 | 0.071 | 0.221 | 5 Hydroxytryptamine 3E antagonist | 0.177 0.113 DB02362 0.221 0.036 DBMET03291 0.197 0.068 DBMET03290 | DBMET03291 | |
| 0.158 | 0.033 | 0.158 | Microtubule formation inhibitor | 0.147 0.039 DB02362 0.13 0.051 DBMET03291 0.1 0.091 DBMET03292 0.124 0.056 DBMET03290 | ||
| 0.131 | 0.008 | 0.131 | Transcription factor AP-1 inhibitor | 0.126 0.009 DBMET03291 0.066 0.036 DBMET03292 | ||
| 0.155 | 0.033 | 0.155 | GABA receptor agonist | 0.109 0.067 DBMET03291 | ||
| 0.134 | 0.013 | 0.134 | Calcium channel L-type blocker | 0.107 0.021 DBMET03291 | ||
| 0.18 | 0.058 | 0.223 | ATPase inhibitor | 0.167 0.075 DB02362 0.221 0.023 DBMET03291 0.223 0.023 DBMET03292 0.207 0.032 DBMET03290 | DBMET03292 | |
| 0.125 | 0.004 | 0.143 | Glutamate (mGluR group III) antagonist | 0.143 0.004 DB02362 0.056 0.016 DBMET03291 0.094 0.005 DBMET03292 0.061 0.013 DBMET03290 | DB02362 | |
| 0.153 | 0.032 | 0.153 | Calcium channel (voltage-sensitive) blocker | 0.132 0.045 DBMET03291 | ||
| 0.128 | 0.007 | 0.128 | Leukocyte elastase inhibitor | 0.058 0.019 DB02362 0.099 0.01 DBMET03291 0.053 0.022 DBMET03290 | ||
| 0.132 | 0.013 | 0.132 | Interferon agonist | 0.12 0.017 DB02362 0.075 0.061 DBMET03291 0.073 0.065 DBMET03290 | ||
| 0.141 | 0.023 | 0.148 | Anabolic | 0.148 0.019 DB02362 0.125 0.035 DBMET03291 0.098 0.066 DBMET03292 0.137 0.026 DBMET03290 | DB02362 | |
| 0.122 | 0.007 | 0.122 | Purinergic P2Y antagonist | 0.076 0.014 DB02362 0.091 0.01 DBMET03291 0.056 0.021 DBMET03290 | ||
| 0.124 | 0.011 | 0.223 | Purinergic P2X1 antagonist | 0.223 0.003 DB02362 0.062 0.041 DBMET03291 0.157 0.006 DBMET03290 | DB02362 | |
| 0.141 | 0.028 | 0.29 | Creatine kinase inhibitor | 0.29 0.004 DB02362 0.093 0.068 DBMET03291 0.092 0.069 DBMET03292 0.21 0.009 DBMET03290 | DB02362 | |
| 0.125 | 0.012 | 0.207 | Carbonic anhydrase VB inhibitor | 0.207 0.005 DB02362 0.078 0.023 DBMET03291 0.137 0.01 DBMET03290 | DB02362 | |
| 0.117 | 0.005 | 0.118 | Potassium channel intermediate-conductance Ca-activated blocker | 0.065 0.034 DB02362 0.08 0.017 DBMET03291 0.118 0.005 DBMET03292 | DBMET03292 | |
| 0.139 | 0.028 | 0.222 | DOPA decarboxylase inhibitor | 0.222 0.005 DB02362 0.093 0.091 DBMET03291 0.147 0.023 DBMET03290 | DB02362 | |
| 0.136 | 0.025 | 0.328 | Electrolyte absorption antagonist | 0.328 0.004 DB02362 0.121 0.035 DBMET03291 0.289 0.004 DBMET03290 | DB02362 | |
| 0.123 | 0.012 | 0.253 | D-Ala-D-Ala ligase inhibitor | 0.253 0.003 DB02362 0.094 0.038 DBMET03291 0.165 0.004 DBMET03290 | DB02362 | |
| 0.164 | 0.053 | 0.235 | Hemostatic | 0.235 0.024 DB02362 0.162 0.055 DBMET03291 0.222 0.026 DBMET03290 | DB02362 | |
| 0.136 | 0.026 | 0.325 | Alcohol dehydrogenase inhibitor | 0.325 0.005 DB02362 0.097 0.056 DBMET03291 0.222 0.01 DBMET03290 | DB02362 | |
| 0.15 | 0.045 | 0.219 | Adenylate cyclase inhibitor | 0.219 0.023 DB02362 0.142 0.051 DBMET03290 | DB02362 | |
| 0.179 | 0.074 | 0.273 | Dual specificity phosphatase 3 inhibitor | 0.273 0.034 DB02362 0.146 0.1 DBMET03291 0.204 0.059 DBMET03290 | DB02362 | |
| 0.115 | 0.012 | 0.115 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.105 0.013 DB02362 0.059 0.035 DBMET03291 0.062 0.032 DBMET03292 0.053 0.044 DBMET03290 | ||
| 0.13 | 0.027 | 0.158 | MAP kinase kinase 1 inhibitor | 0.158 0.014 DB02362 0.09 0.069 DBMET03291 0.09 0.071 DBMET03292 0.11 0.045 DBMET03290 | DB02362 | |
| 0.146 | 0.043 | 0.344 | Cystathionine beta-synthase inhibitor | 0.344 0.007 DB02362 0.182 0.029 DBMET03290 | DB02362 | |
| 0.107 | 0.005 | 0.107 | GABA B receptor antagonist | 0.063 0.011 DB02362 0.039 0.037 DBMET03291 0.049 0.02 DBMET03292 | ||
| 0.208 | 0.106 | 0.264 | Calpain inhibitor | 0.264 0.053 DBMET03291 0.233 0.081 DBMET03290 | DBMET03291 | |
| 0.106 | 0.005 | 0.146 | Glutamate (mGluR4) antagonist | 0.146 0.004 DB02362 0.059 0.014 DBMET03291 0.092 0.006 DBMET03292 0.084 0.008 DBMET03290 | DB02362 | |
| 0.107 | 0.007 | 0.24 | Kainate receptor antagonist | 0.24 0.004 DB02362 0.082 0.009 DBMET03292 0.076 0.011 DBMET03290 | DB02362 | |
| 0.12 | 0.019 | 0.143 | Bile acid receptor antagonist | 0.143 0.009 DB02362 0.102 0.045 DBMET03291 0.123 0.017 DBMET03290 | DB02362 | |
| 0.111 | 0.01 | 0.14 | GABA B receptor agonist | 0.14 0.005 DB02362 0.102 0.015 DBMET03291 0.088 0.028 DBMET03292 0.121 0.007 DBMET03290 | DB02362 | |
| 0.123 | 0.024 | 0.251 | Phosphofructokinase-1 inhibitor | 0.251 0.007 DB02362 0.074 0.045 DBMET03292 0.13 0.022 DBMET03290 | DB02362 | |
| 0.15 | 0.052 | 0.172 | Farnesoid X receptor antagonist | 0.172 0.033 DB02362 0.134 0.075 DBMET03291 0.129 0.085 DBMET03292 0.154 0.048 DBMET03290 | DB02362 | |
| 0.116 | 0.019 | 0.124 | Adenosine A3 receptor antagonist | 0.071 0.056 DB02362 0.124 0.017 DBMET03291 0.078 0.046 DBMET03290 | DBMET03291 | |
| 0.128 | 0.032 | 0.135 | Phosphodiesterase 7B inhibitor | 0.135 0.028 DB02362 | DB02362 | |
| 0.113 | 0.016 | 0.294 | Argininosuccinate synthase inhibitor | 0.294 0.004 DB02362 0.169 0.01 DBMET03290 | DB02362 | |
| 0.158 | 0.062 | 0.174 | CF transmembrane conductance regulator agonist | 0.174 0.042 DB02362 0.141 0.094 DBMET03291 0.155 0.067 DBMET03290 | DB02362 | |
| 0.1 | 0.005 | 0.1 | Glutamate (mGluR1a) antagonist | 0.05 0.02 DB02362 0.048 0.022 DBMET03291 | ||
| 0.16 | 0.066 | 0.225 | Interferon gamma antagonist | 0.225 0.034 DB02362 0.14 0.093 DBMET03291 0.188 0.046 DBMET03290 | DB02362 | |
| 0.151 | 0.057 | 0.151 | Nav1.2 sodium channel blocker | 0.128 0.075 DBMET03291 | ||
| 0.124 | 0.03 | 0.125 | Protein kinase C zeta inhibitor | 0.125 0.029 DB02362 | DB02362 | |
| 0.103 | 0.011 | 0.109 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.109 0.009 DB02362 0.08 0.036 DBMET03292 0.069 0.063 DBMET03290 | DB02362 | |
| 0.102 | 0.012 | 0.102 | Interferon inducer | 0.091 0.017 DB02362 0.065 0.043 DBMET03291 0.061 0.051 DBMET03290 | ||
| 0.141 | 0.051 | 0.178 | Alkylator | 0.163 0.04 DB02362 0.107 0.081 DBMET03291 0.178 0.034 DBMET03292 0.121 0.068 DBMET03290 | DBMET03292 | |
| 0.219 | 0.131 | 0.248 | Hypoxia-inducible factor 1 alpha inhibitor | 0.248 0.103 DB02362 | DB02362 | |
| 0.163 | 0.075 | 0.184 | Neurotensin receptor agonist | 0.183 0.047 DB02362 0.162 0.075 DBMET03291 0.184 0.045 DBMET03290 | DBMET03290 | |
| 0.112 | 0.024 | 0.334 | Glutamate decarboxylase inhibitor | 0.334 0.003 DB02362 0.067 0.058 DBMET03291 0.122 0.02 DBMET03292 0.194 0.007 DBMET03290 | DB02362 | |
| 0.113 | 0.027 | 0.153 | Glutathione S-transferase inhibitor | 0.101 0.037 DB02362 0.153 0.011 DBMET03291 0.092 0.046 DBMET03292 0.136 0.016 DBMET03290 | DBMET03291 | |
| 0.162 | 0.075 | 0.183 | Heat shock protein 90 alpha antagonist | 0.183 0.061 DB02362 0.136 0.103 DBMET03291 0.156 0.08 DBMET03292 0.155 0.081 DBMET03290 | DB02362 | |
| 0.118 | 0.032 | 0.174 | ABCA1 expression enhancer | 0.174 0.013 DB02362 0.083 0.08 DBMET03291 0.115 0.035 DBMET03290 | DB02362 | |
| 0.091 | 0.005 | 0.091 | Fructose-1,6-bisphosphatase inhibitor | 0.087 0.005 DB02362 0.057 0.019 DBMET03291 0.054 0.021 DBMET03290 | ||
| 0.136 | 0.051 | 0.147 | Interleukin 1b antagonist | 0.147 0.042 DB02362 0.113 0.068 DBMET03291 0.122 0.061 DBMET03290 | DB02362 | |
| 0.113 | 0.029 | 0.113 | Transcription factor NF kappa B stimulant | 0.103 0.036 DB02362 0.105 0.035 DBMET03291 0.096 0.043 DBMET03290 | ||
| 0.1 | 0.016 | 0.1 | GABA receptor antagonist | 0.07 0.026 DBMET03292 | ||
| 0.113 | 0.028 | 0.12 | Macrophage migration inhibitory factor inhibitor | 0.12 0.025 DB02362 | DB02362 | |
| 0.103 | 0.019 | 0.195 | Glycine receptor agonist | 0.195 0.004 DB02362 0.102 0.02 DBMET03290 | DB02362 | |
| 0.087 | 0.003 | 0.27 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.27 0.001 DB02362 0.045 0.021 DBMET03291 0.05 0.014 DBMET03292 0.095 0.003 DBMET03290 | DB02362 | |
| 0.17 | 0.086 | 0.17 | MAP kinase kinase 5 inhibitor | |||
| 0.093 | 0.01 | 0.237 | CD45 antagonist | 0.237 0.004 DB02362 0.073 0.014 DBMET03291 0.141 0.006 DBMET03290 | DB02362 | |
| 0.289 | 0.207 | 0.408 | Caspase 9 stimulant | 0.313 0.18 DB02362 0.368 0.132 DBMET03291 0.261 0.24 DBMET03292 0.408 0.106 DBMET03290 | DBMET03290 | |
| 0.089 | 0.007 | 0.225 | Dihydroorotase inhibitor | 0.109 0.005 DB02362 0.171 0.004 DBMET03291 0.058 0.018 DBMET03292 0.225 0.003 DBMET03290 | DBMET03290 | |
| 0.091 | 0.011 | 0.095 | Sphingosine 1-phosphate receptor 3 antagonist | 0.079 0.017 DB02362 0.095 0.009 DBMET03291 0.088 0.012 DBMET03290 | DBMET03291 | |
| 0.097 | 0.017 | 0.266 | Neuraminidase (influenza) inhibitor | 0.186 0.005 DB02362 0.218 0.004 DBMET03291 0.266 0.004 DBMET03290 | DBMET03290 | |
| 0.097 | 0.018 | 0.13 | Maillard reaction inhibitor | 0.13 0.008 DB02362 0.053 0.04 DBMET03291 0.088 0.022 DBMET03290 | DB02362 | |
| 0.11 | 0.031 | 0.11 | Interleukin 5 antagonist | 0.101 0.04 DB02362 0.1 0.041 DBMET03291 0.09 0.054 DBMET03290 | ||
| 0.095 | 0.017 | 0.095 | GABA A receptor antagonist | 0.058 0.032 DBMET03292 | ||
| 0.086 | 0.008 | 0.176 | Dihydroorotate oxidase inhibitor | 0.142 0.003 DB02362 0.111 0.004 DBMET03291 0.072 0.015 DBMET03292 0.176 0.002 DBMET03290 | DBMET03290 | |
| 0.134 | 0.058 | 0.175 | DNA polymerase I inhibitor | 0.175 0.037 DB02362 0.124 0.065 DBMET03290 | DB02362 | |
| 0.142 | 0.066 | 0.181 | Alkaline phosphatase inhibitor | 0.181 0.041 DB02362 0.119 0.087 DBMET03291 0.15 0.06 DBMET03290 | DB02362 | |
| 0.128 | 0.052 | 0.183 | Interleukin 8 antagonist | 0.183 0.018 DB02362 0.125 0.055 DBMET03290 | DB02362 | |
| 0.081 | 0.007 | 0.11 | Retinoid X receptor agonist | 0.11 0.004 DB02362 0.051 0.018 DBMET03292 0.058 0.014 DBMET03290 | DB02362 | |
| 0.11 | 0.037 | 0.152 | Histamine N-methyltransferase inhibitor | 0.152 0.013 DB02362 0.095 0.051 DBMET03290 | DB02362 | |
| 0.133 | 0.061 | 0.133 | Vanilloid 1 agonist | 0.118 0.094 DB02362 0.133 0.06 DBMET03291 0.123 0.081 DBMET03290 | ||
| 0.081 | 0.009 | 0.093 | Adenosine deaminase inhibitor | 0.085 0.008 DB02362 0.064 0.018 DBMET03291 0.093 0.006 DBMET03292 0.067 0.015 DBMET03290 | DBMET03292 | |
| 0.144 | 0.071 | 0.245 | Cell wall synthesis inhibitor | 0.245 0.017 DB02362 0.146 0.069 DBMET03291 0.245 0.017 DBMET03290 | DBMET03290 | |
| 0.099 | 0.027 | 0.188 | Carbonic anhydrase V inhibitor | 0.188 0.008 DB02362 0.101 0.026 DBMET03291 0.179 0.009 DBMET03290 | DB02362 | |
| 0.113 | 0.042 | 0.132 | Interleukin 1 beta converting enzyme inhibitor | 0.095 0.064 DB02362 0.132 0.027 DBMET03291 0.115 0.04 DBMET03290 | DBMET03291 | |
| 0.098 | 0.027 | 0.107 | Estrogen-related receptor beta agonist | 0.107 0.018 DB02362 0.087 0.048 DBMET03290 | DB02362 | |
| 0.088 | 0.017 | 0.088 | Exportin-1 inhibitor | 0.066 0.052 DB02362 0.067 0.05 DBMET03291 | ||
| 0.13 | 0.06 | 0.183 | Papain-like protease (SARS coronavirus) inhibitor | 0.153 0.031 DB02362 0.153 0.031 DBMET03291 0.183 0.015 DBMET03290 | DBMET03290 | |
| 0.093 | 0.023 | 0.153 | Carbamoyl phosphate synthetase inhibitor | 0.153 0.011 DB02362 0.068 0.036 DBMET03290 | DB02362 | |
| 0.164 | 0.095 | 0.164 | Hepatoprotectant | 0.164 0.095 DB02362 | ||
| 0.089 | 0.02 | 0.259 | Neuraminidase inhibitor | 0.161 0.005 DB02362 0.199 0.004 DBMET03291 0.259 0.003 DBMET03290 | DBMET03290 | |
| 0.131 | 0.063 | 0.153 | Nav1.3 sodium channel blocker | 0.153 0.046 DBMET03291 0.109 0.086 DBMET03290 | DBMET03291 | |
| 0.088 | 0.021 | 0.182 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.17 0.005 DB02362 0.097 0.018 DBMET03291 0.182 0.005 DBMET03290 | DBMET03290 | |
| 0.079 | 0.013 | 0.079 | 5 Hydroxytryptamine 4 antagonist | 0.049 0.041 DB02362 | ||
| 0.08 | 0.015 | 0.08 | Calcium channel P-type blocker | 0.063 0.046 DB02362 | ||
| 0.123 | 0.059 | 0.123 | Calcium channel N-type blocker | 0.103 0.09 DBMET03291 | ||
| 0.108 | 0.044 | 0.114 | Potassium channel (Voltage-sensitive) activator | 0.114 0.038 DBMET03291 | DBMET03291 | |
| 0.069 | 0.005 | 0.148 | Glutamate (mGluR8) agonist | 0.148 0.002 DB02362 0.046 0.015 DBMET03291 0.088 0.004 DBMET03290 | DB02362 | |
| 0.131 | 0.07 | 0.214 | Interleukin 4 antagonist | 0.168 0.036 DB02362 0.173 0.033 DBMET03291 0.214 0.019 DBMET03290 | DBMET03290 | |
| 0.145 | 0.084 | 0.288 | Protein-tyrosine phosphatase inhibitor | 0.288 0.021 DB02362 0.135 0.096 DBMET03291 0.235 0.035 DBMET03290 | DB02362 | |
| 0.131 | 0.07 | 0.248 | NADPH oxidase inhibitor | 0.248 0.021 DB02362 0.108 0.1 DBMET03291 0.2 0.035 DBMET03290 | DB02362 | |
| 0.072 | 0.011 | 0.072 | Sodium/calcium exchanger inhibitor | 0.059 0.021 DB02362 | ||
| 0.116 | 0.056 | 0.193 | Protein kinase C gamma inhibitor | 0.193 0.015 DB02362 0.135 0.041 DBMET03290 | DB02362 | |
| 0.118 | 0.058 | 0.118 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.092 | 0.033 | 0.173 | Aminopeptidase I inhibitor | 0.173 0.009 DB02362 0.073 0.05 DBMET03291 0.148 0.013 DBMET03290 | DB02362 | |
| 0.123 | 0.066 | 0.16 | DNA repair enzyme inhibitor | 0.16 0.024 DB02362 0.127 0.059 DBMET03290 | DB02362 | |
| 0.065 | 0.008 | 0.13 | Retinoic acid alpha receptor agonist | 0.13 0.003 DB02362 0.055 0.011 DBMET03291 0.048 0.016 DBMET03292 0.094 0.004 DBMET03290 | DB02362 | |
| 0.069 | 0.012 | 0.074 | Immunoglobulin Fc receptor antagonist | 0.074 0.008 DB02362 0.056 0.034 DBMET03291 0.061 0.023 DBMET03292 0.062 0.021 DBMET03290 | DB02362 | |
| 0.072 | 0.016 | 0.075 | Alpha-mannosidase inhibitor | 0.075 0.013 DB02362 0.063 0.023 DBMET03291 0.061 0.025 DBMET03292 0.064 0.022 DBMET03290 | DB02362 | |
| 0.109 | 0.053 | 0.19 | Xanthine oxidase inhibitor | 0.19 0.022 DB02362 0.088 0.075 DBMET03291 0.154 0.033 DBMET03290 | DB02362 | |
| 0.081 | 0.026 | 0.088 | Protease 3C (Human rhinovirus) inhibitor | 0.058 0.057 DB02362 0.088 0.021 DBMET03291 0.067 0.041 DBMET03290 | DBMET03291 | |
| 0.065 | 0.01 | 0.136 | Retinoid X alpha receptor agonist | 0.136 0.003 DB02362 0.064 0.01 DBMET03290 | DB02362 | |
| 0.106 | 0.051 | 0.111 | Nitric-oxide synthase inhibitor | 0.111 0.045 DB02362 | DB02362 | |
| 0.072 | 0.018 | 0.082 | Diacylglycerol O-acyltransferase inhibitor | 0.082 0.013 DB02362 0.068 0.021 DBMET03291 0.078 0.015 DBMET03290 | DB02362 | |
| 0.069 | 0.015 | 0.096 | Lysophosphatidic acid 3 receptor antagonist | 0.092 0.006 DB02362 0.067 0.016 DBMET03291 0.096 0.005 DBMET03290 | DBMET03290 | |
| 0.095 | 0.042 | 0.095 | GABA A receptor agonist | 0.081 0.061 DBMET03291 | ||
| 0.062 | 0.009 | 0.067 | Dihydrofolate reductase inhibitor | 0.067 0.007 DB02362 | DB02362 | |
| 0.149 | 0.096 | 0.254 | Dual specificity phosphatase inhibitor | 0.254 0.037 DB02362 0.139 0.108 DBMET03291 0.202 0.054 DBMET03290 | DB02362 | |
| 0.077 | 0.024 | 0.092 | MDM2 inhibitor | 0.092 0.01 DB02362 0.074 0.029 DBMET03290 | DB02362 | |
| 0.073 | 0.02 | 0.162 | Dihydroorotate dehydrogenase inhibitor | 0.098 0.012 DB02362 0.122 0.007 DBMET03291 0.162 0.005 DBMET03290 | DBMET03290 | |
| 0.079 | 0.027 | 0.079 | Phosphodiesterase VII inhibitor | 0.068 0.037 DB02362 | ||
| 0.067 | 0.015 | 0.067 | Squalene epoxidase inhibitor | 0.052 0.031 DBMET03291 0.046 0.044 DBMET03292 | ||
| 0.093 | 0.042 | 0.093 | Histamine H2 receptor antagonist | 0.09 0.047 DB02362 | ||
| 0.062 | 0.011 | 0.062 | Cytokine production stimulant | 0.046 0.04 DB02362 0.046 0.04 DBMET03291 | ||
| 0.074 | 0.024 | 0.192 | Ornithine carbamoyltransferase inhibitor | 0.192 0.007 DB02362 0.101 0.016 DBMET03290 | DB02362 | |
| 0.074 | 0.024 | 0.074 | Phosphodiesterase 1C inhibitor | 0.069 0.03 DB02362 0.062 0.043 DBMET03291 0.058 0.053 DBMET03292 0.061 0.047 DBMET03290 | ||
| 0.09 | 0.04 | 0.09 | Nicotinic alpha4beta2 receptor antagonist | 0.067 0.065 DB02362 | ||
| 0.106 | 0.058 | 0.106 | Gastric antisecretory | 0.096 0.07 DBMET03291 | ||
| 0.098 | 0.05 | 0.098 | Thioredoxin inhibitor | 0.094 0.055 DB02362 | ||
| 0.083 | 0.035 | 0.168 | Carbonic anhydrase VA inhibitor | 0.168 0.008 DB02362 0.086 0.032 DBMET03291 0.163 0.009 DBMET03290 | DB02362 | |
| 0.067 | 0.02 | 0.078 | Epithelial sodium channel blocker | 0.078 0.013 DB02362 | DB02362 | |
| 0.071 | 0.025 | 0.077 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 DBMET03291 0.057 0.039 DBMET03290 | DBMET03291 | |
| 0.076 | 0.03 | 0.076 | Adenosine A1 receptor antagonist | 0.06 0.039 DB02362 | ||
| 0.061 | 0.016 | 0.081 | Mannosidase inhibitor | 0.081 0.008 DB02362 0.051 0.024 DBMET03291 0.049 0.027 DBMET03292 0.063 0.015 DBMET03290 | DB02362 | |
| 0.081 | 0.036 | 0.085 | Sphingosine 1-phosphate receptor 4 agonist | 0.085 0.033 DB02362 | DB02362 | |
| 0.119 | 0.074 | 0.17 | MAP kinase kinase inhibitor | 0.17 0.041 DB02362 0.156 0.048 DBMET03292 | DB02362 | |
| 0.076 | 0.031 | 0.084 | Beta adrenoreceptor antagonist | 0.059 0.057 DB02362 0.084 0.024 DBMET03291 0.068 0.041 DBMET03290 | DBMET03291 | |
| 0.065 | 0.021 | 0.105 | Adenine nucleotide translocase inhibitor | 0.105 0.004 DB02362 0.068 0.017 DBMET03291 0.055 0.041 DBMET03292 0.1 0.005 DBMET03290 | DB02362 | |
| 0.09 | 0.047 | 0.091 | Inducible nitric-oxide synthase inhibitor | 0.091 0.046 DB02362 | DB02362 | |
| 0.075 | 0.032 | 0.088 | CDC25B inhibitor | 0.088 0.022 DB02362 0.062 0.048 DBMET03290 | DB02362 | |
| 0.076 | 0.033 | 0.076 | Potassium channel (ATP-sensitive) blocker | 0.068 0.045 DB02362 0.066 0.049 DBMET03291 0.061 0.058 DBMET03290 | ||
| 0.057 | 0.016 | 0.062 | Benzodiazepine antagonist | 0.062 0.011 DBMET03291 | DBMET03291 | |
| 0.053 | 0.011 | 0.208 | Glutamate (mGluR3) antagonist | 0.208 0.003 DB02362 0.054 0.01 DBMET03290 | DB02362 | |
| 0.072 | 0.031 | 0.211 | NMDA 2C receptor antagonist | 0.211 0.005 DB02362 0.109 0.013 DBMET03290 | DB02362 | |
| 0.066 | 0.026 | 0.161 | NMDA 2A receptor antagonist | 0.161 0.006 DB02362 0.074 0.022 DBMET03290 | DB02362 | |
| 0.153 | 0.113 | 0.153 | P-glycoprotein inhibitor | |||
| 0.112 | 0.072 | 0.17 | Caspase 3 inhibitor | 0.119 0.062 DB02362 0.163 0.02 DBMET03291 0.17 0.017 DBMET03290 | DBMET03290 | |
| 0.081 | 0.042 | 0.111 | MAP kinase kinase 7 inhibitor | 0.111 0.006 DB02362 0.095 0.017 DBMET03290 | DB02362 | |
| 0.059 | 0.02 | 0.11 | Carbonic anhydrase VII inhibitor | 0.081 0.013 DB02362 0.084 0.012 DBMET03291 0.11 0.009 DBMET03290 | DBMET03290 | |
| 0.189 | 0.15 | 0.382 | Transcription factor STAT3 inhibitor | 0.241 0.09 DB02362 0.32 0.044 DBMET03291 0.382 0.023 DBMET03290 | DBMET03290 | |
| 0.056 | 0.017 | 0.118 | AICAR transformylase inhibitor | 0.118 0.004 DB02362 0.049 0.023 DBMET03291 0.093 0.005 DBMET03290 | DB02362 | |
| 0.051 | 0.014 | 0.183 | Nicotinic acid receptor agonist | 0.137 0.004 DB02362 0.068 0.009 DBMET03291 0.183 0.004 DBMET03290 | DBMET03290 | |
| 0.074 | 0.038 | 0.106 | Carbonic anhydrase inhibitor | 0.106 0.025 DB02362 0.081 0.035 DBMET03291 0.105 0.025 DBMET03290 | DB02362 | |
| 0.04 | 0.004 | 0.04 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.038 0.005 DB02362 | ||
| 0.06 | 0.025 | 0.139 | Phosphorylase inhibitor | 0.139 0.008 DB02362 0.05 0.03 DBMET03291 0.11 0.012 DBMET03290 | DB02362 | |
| 0.067 | 0.033 | 0.067 | Glutamate (mGluR1) antagonist | 0.066 0.033 DB02362 | ||
| 0.06 | 0.025 | 0.152 | AMPA receptor antagonist | 0.152 0.005 DB02362 0.071 0.02 DBMET03292 0.049 0.032 DBMET03290 | DB02362 | |
| 0.131 | 0.097 | 0.141 | Heat shock protein 90 antagonist | 0.141 0.084 DB02362 | DB02362 | |
| 0.061 | 0.028 | 0.07 | Pregnane X receptor antagonist | 0.07 0.014 DB02362 0.054 0.049 DBMET03291 0.065 0.021 DBMET03290 | DB02362 | |
| 0.065 | 0.032 | 0.099 | Carbonic anhydrase I inhibitor | 0.094 0.02 DB02362 0.077 0.026 DBMET03291 0.099 0.019 DBMET03290 | DBMET03290 | |
| 0.083 | 0.05 | 0.083 | Chymotrypsin inhibitor | 0.08 0.055 DB02362 | ||
| 0.05 | 0.018 | 0.056 | Angiotensin AT1 receptor antagonist | 0.055 0.011 DB02362 0.047 0.022 DBMET03291 0.056 0.01 DBMET03290 | DBMET03290 | |
| 0.051 | 0.019 | 0.137 | NMDA receptor subunit 3A antagonist | 0.137 0.005 DB02362 0.058 0.017 DBMET03290 | DB02362 | |
| 0.086 | 0.055 | 0.153 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.153 0.014 DB02362 0.087 0.053 DBMET03291 0.134 0.019 DBMET03290 | DB02362 | |
| 0.059 | 0.028 | 0.068 | Thromboxane synthase inhibitor | 0.068 0.019 DB02362 0.054 0.039 DBMET03291 0.05 0.049 DBMET03292 0.059 0.029 DBMET03290 | DB02362 | |
| 0.087 | 0.057 | 0.214 | NMDA receptor antagonist | 0.214 0.012 DB02362 0.134 0.029 DBMET03290 | DB02362 | |
| 0.038 | 0.007 | 0.096 | Retinoic acid receptor agonist | 0.096 0.004 DB02362 0.034 0.008 DBMET03291 0.031 0.009 DBMET03292 0.069 0.004 DBMET03290 | DB02362 | |
| 0.121 | 0.09 | 0.173 | Histone deacetylase SIRT1 inhibitor | 0.121 0.09 DB02362 0.169 0.047 DBMET03291 0.173 0.044 DBMET03290 | DBMET03290 | |
| 0.06 | 0.03 | 0.06 | Elastase inhibitor | 0.051 0.04 DBMET03291 | ||
| 0.041 | 0.012 | 0.049 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.049 0.009 DB02362 | DB02362 | |
| 0.062 | 0.033 | 0.1 | Ryanodine receptor antagonist | 0.1 0.004 DB02362 0.058 0.044 DBMET03290 | DB02362 | |
| 0.033 | 0.004 | 0.072 | Neuraminidase (Influenza B) inhibitor | 0.046 0.003 DB02362 0.047 0.003 DBMET03291 0.02 0.018 DBMET03292 0.072 0.002 DBMET03290 | DBMET03290 | |
| 0.054 | 0.025 | 0.054 | Aldosterone antagonist | 0.049 0.03 DBMET03291 | ||
| 0.181 | 0.153 | 0.236 | 5 Hydroxytryptamine 1E antagonist | 0.193 0.139 DB02362 0.236 0.09 DBMET03291 0.236 0.09 DBMET03290 | DBMET03290 | |
| 0.063 | 0.035 | 0.063 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.05 DB02362 | ||
| 0.063 | 0.036 | 0.088 | Carbonic anhydrase IX inhibitor | 0.088 0.024 DB02362 0.054 0.04 DBMET03291 0.074 0.03 DBMET03290 | DB02362 | |
| 0.088 | 0.06 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.056 DBMET03291 | DBMET03291 | |
| 0.063 | 0.036 | 0.141 | Xanthine dehydrogenase inhibitor | 0.141 0.008 DB02362 0.094 0.018 DBMET03290 | DB02362 | |
| 0.096 | 0.069 | 0.136 | Glutamate (mGluR7) agonist | 0.107 0.047 DB02362 0.13 0.022 DBMET03291 0.136 0.018 DBMET03290 | DBMET03290 | |
| 0.093 | 0.067 | 0.097 | Phosphodiesterase 6D inhibitor | 0.097 0.057 DB02362 0.088 0.08 DBMET03291 0.093 0.067 DBMET03290 | DB02362 | |
| 0.088 | 0.062 | 0.088 | Phosphodiesterase I inhibitor | 0.084 0.069 DB02362 | ||
| 0.054 | 0.028 | 0.139 | Topoisomerase II beta inhibitor | 0.139 0.005 DB02362 0.047 0.037 DBMET03291 0.112 0.008 DBMET03290 | DB02362 | |
| 0.042 | 0.018 | 0.07 | Integrin alpha2 antagonist | 0.07 0.005 DB02362 0.04 0.02 DBMET03290 | DB02362 | |
| 0.081 | 0.056 | 0.112 | Adrenaline agonist | 0.112 0.03 DB02362 0.074 0.065 DBMET03291 0.099 0.038 DBMET03290 | DB02362 | |
| 0.084 | 0.059 | 0.128 | Myeloperoxidase inhibitor | 0.128 0.016 DB02362 | DB02362 | |
| 0.147 | 0.123 | 0.221 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.221 0.062 DB02362 0.174 0.098 DBMET03290 | DB02362 | |
| 0.04 | 0.016 | 0.05 | Purinergic P2Y2 antagonist | 0.05 0.01 DB02362 0.031 0.028 DBMET03291 0.035 0.021 DBMET03290 | DB02362 | |
| 0.057 | 0.032 | 0.079 | Leukotriene B4 antagonist | 0.079 0.016 DB02362 0.051 0.043 DBMET03290 | DB02362 | |
| 0.051 | 0.027 | 0.07 | Glucose-6-phosphate isomerase inhibitor | 0.07 0.012 DB02362 0.044 0.041 DBMET03291 0.061 0.017 DBMET03292 0.054 0.024 DBMET03290 | DB02362 | |
| 0.036 | 0.014 | 0.077 | Glutamate (mGluR3) agonist | 0.077 0.003 DB02362 0.031 0.027 DBMET03291 0.058 0.004 DBMET03290 | DB02362 | |
| 0.054 | 0.031 | 0.057 | Beta 2 adrenoreceptor antagonist | 0.046 0.043 DB02362 0.057 0.027 DBMET03291 0.051 0.036 DBMET03290 | DBMET03291 | |
| 0.104 | 0.082 | 0.138 | Cholesterol synthesis inhibitor | 0.138 0.051 DB02362 0.11 0.075 DBMET03290 | DB02362 | |
| 0.032 | 0.01 | 0.054 | Integrin alpha2beta1 antagonist | 0.054 0.004 DB02362 0.028 0.016 DBMET03290 | DB02362 | |
| 0.114 | 0.093 | 0.114 | Toll-Like receptor 9 antagonist | |||
| 0.038 | 0.017 | 0.044 | Angiotensin II receptor antagonist | 0.044 0.01 DB02362 0.034 0.024 DBMET03291 0.043 0.011 DBMET03290 | DB02362 | |
| 0.048 | 0.027 | 0.148 | Neuraminidase (Influenza A) inhibitor | 0.09 0.004 DB02362 0.089 0.004 DBMET03291 0.148 0.003 DBMET03290 | DBMET03290 | |
| 0.049 | 0.028 | 0.054 | Adenylate cyclase 1 inhibitor | 0.054 0.023 DB02362 | DB02362 | |
| 0.105 | 0.085 | 0.126 | M18 aspartyl aminopeptidase inhibitor | 0.126 0.066 DB02362 | DB02362 | |
| 0.045 | 0.026 | 0.058 | Toll-Like receptor 2 agonist | 0.058 0.02 DBMET03291 0.036 0.034 DBMET03290 | DBMET03291 | |
| 0.032 | 0.013 | 0.097 | Methionyl aminopeptidase 2 inhibitor | 0.097 0.004 DB02362 0.061 0.005 DBMET03290 | DB02362 | |
| 0.024 | 0.006 | 0.055 | Carbonic anhydrase VIII inhibitor | 0.032 0.004 DB02362 0.043 0.003 DBMET03291 0.055 0.002 DBMET03290 | DBMET03290 | |
| 0.024 | 0.006 | 0.055 | Carbonic anhydrase X inhibitor | 0.032 0.004 DB02362 0.043 0.003 DBMET03291 0.055 0.002 DBMET03290 | DBMET03290 | |
| 0.046 | 0.027 | 0.08 | Carbonic anhydrase IV inhibitor | 0.073 0.013 DB02362 0.058 0.02 DBMET03291 0.08 0.011 DBMET03290 | DBMET03290 | |
| 0.029 | 0.011 | 0.053 | Glutamate (mGluR1) agonist | 0.053 0.005 DB02362 0.023 0.021 DBMET03291 0.034 0.007 DBMET03290 | DB02362 | |
| 0.13 | 0.112 | 0.277 | Mcl-1 antagonist | 0.277 0.028 DB02362 0.123 0.122 DBMET03291 0.221 0.046 DBMET03290 | DB02362 | |
| 0.033 | 0.015 | 0.033 | Elastase 2B inhibitor | 0.03 0.024 DBMET03291 | ||
| 0.033 | 0.015 | 0.033 | Elastase 3A inhibitor | 0.03 0.024 DBMET03291 | ||
| 0.033 | 0.015 | 0.033 | Elastase 3B inhibitor | 0.03 0.024 DBMET03291 | ||
| 0.066 | 0.048 | 0.066 | Acetylcholine M5 receptor agonist | |||
| 0.053 | 0.036 | 0.089 | Carbonic anhydrase XII inhibitor | 0.089 0.022 DB02362 0.05 0.038 DBMET03291 0.077 0.026 DBMET03290 | DB02362 | |
| 0.022 | 0.005 | 0.022 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.041 | 0.024 | 0.066 | Membrane dipeptidase inhibitor | 0.066 0.008 DB02362 0.057 0.011 DBMET03290 | DB02362 | |
| 0.026 | 0.009 | 0.05 | Retinoic acid gamma receptor agonist | 0.05 0.003 DB02362 0.023 0.014 DBMET03291 0.025 0.011 DBMET03292 0.038 0.004 DBMET03290 | DB02362 | |
| 0.03 | 0.013 | 0.05 | Calcium-sensing receptor agonist | 0.045 0.006 DB02362 0.031 0.013 DBMET03291 0.05 0.005 DBMET03290 | DBMET03290 | |
| 0.055 | 0.039 | 0.086 | Carbonic anhydrase II inhibitor | 0.085 0.023 DB02362 0.062 0.034 DBMET03291 0.086 0.023 DBMET03290 | DBMET03290 | |
| 0.046 | 0.029 | 0.051 | Beta adrenoreceptor agonist | 0.051 0.016 DB02362 0.046 0.027 DBMET03291 0.051 0.016 DBMET03290 | DBMET03290 | |
| 0.024 | 0.008 | 0.087 | Retinoic acid beta receptor agonist | 0.087 0.003 DB02362 0.02 0.013 DBMET03291 0.044 0.004 DBMET03290 | DB02362 | |
| 0.07 | 0.054 | 0.093 | Cathepsin G inhibitor | 0.093 0.036 DB02362 0.071 0.052 DBMET03290 | DB02362 | |
| 0.096 | 0.08 | 0.115 | Factor V inhibitor | 0.115 0.044 DB02362 0.106 0.057 DBMET03290 | DB02362 | |
| 0.052 | 0.036 | 0.056 | Phosphodiesterase 7A inhibitor | 0.056 0.028 DB02362 | DB02362 | |
| 0.04 | 0.024 | 0.063 | Retinoid X receptor antagonist | 0.063 0.005 DB02362 0.037 0.029 DBMET03292 0.058 0.007 DBMET03290 | DB02362 | |
| 0.061 | 0.046 | 0.061 | Nitric oxide donor | 0.06 0.048 DBMET03291 | ||
| 0.056 | 0.04 | 0.077 | Leukotriene C antagonist | 0.068 0.016 DB02362 0.062 0.025 DBMET03291 0.077 0.009 DBMET03290 | DBMET03290 | |
| 0.092 | 0.077 | 0.092 | Nav1.1 sodium channel blocker | |||
| 0.089 | 0.074 | 0.108 | Sphingomyelinase inhibitor | 0.108 0.051 DBMET03292 | DBMET03292 | |
| 0.049 | 0.035 | 0.057 | Adenosine A2b receptor antagonist | 0.057 0.027 DBMET03291 | DBMET03291 | |
| 0.034 | 0.019 | 0.051 | Methionyl aminopeptidase 1 inhibitor | 0.039 0.013 DB02362 0.044 0.009 DBMET03291 0.051 0.006 DBMET03290 | DBMET03290 | |
| 0.053 | 0.038 | 0.107 | Heparanase inhibitor | 0.078 0.007 DB02362 0.073 0.01 DBMET03291 0.107 0.004 DBMET03290 | DBMET03290 | |
| 0.035 | 0.021 | 0.054 | Retinoid X alpha receptor antagonist | 0.054 0.005 DB02362 0.033 0.025 DBMET03292 0.05 0.006 DBMET03290 | DB02362 | |
| 0.069 | 0.055 | 0.084 | Peroxisome proliferator-activated receptor gamma antagonist | 0.084 0.028 DB02362 0.076 0.039 DBMET03290 | DB02362 | |
| 0.036 | 0.022 | 0.134 | Fumarate hydratase inhibitor | 0.134 0.004 DB02362 0.065 0.009 DBMET03290 | DB02362 | |
| 0.036 | 0.023 | 0.049 | Tryptophan 5 hydroxylase inhibitor | 0.049 0.005 DB02362 0.034 0.031 DBMET03290 | DB02362 | |
| 0.035 | 0.022 | 0.037 | Calcium-independent phospholipase A2 inhibitor | 0.037 0.016 DB02362 0.033 0.029 DBMET03291 0.034 0.023 DBMET03290 | DB02362 | |
| 0.078 | 0.065 | 0.078 | Caspase 7 inhibitor | |||
| 0.021 | 0.008 | 0.027 | Methylmalonyl-CoA mutase inhibitor | 0.027 0.003 DB02362 0.023 0.005 DBMET03290 | DB02362 | |
| 0.029 | 0.016 | 0.104 | Kynurenine 3 monooxygenase inhibitor | 0.104 0.004 DB02362 0.032 0.014 DBMET03290 | DB02362 | |
| 0.132 | 0.119 | 0.144 | Antipruritic | 0.144 0.102 DB02362 0.129 0.125 DBMET03290 | DB02362 | |
| 0.035 | 0.023 | 0.035 | Calcitonin receptor agonist | |||
| 0.029 | 0.017 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.008 DB02362 | DB02362 | |
| 0.1 | 0.088 | 0.164 | CDK3/cyclin E inhibitor | 0.101 0.085 DB02362 0.158 0.022 DBMET03291 0.164 0.018 DBMET03290 | DBMET03290 | |
| 0.101 | 0.089 | 0.101 | Acetylcholine muscarinic antagonist | |||
| 0.022 | 0.01 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.071 | 0.06 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.058 DBMET03291 | DBMET03291 | |
| 0.056 | 0.046 | 0.059 | Androgen agonist | 0.058 0.043 DB02362 0.054 0.049 DBMET03291 0.059 0.042 DBMET03290 | DBMET03290 | |
| 0.128 | 0.118 | 0.149 | Melanin inhibitor | 0.149 0.083 DB02362 0.141 0.095 DBMET03290 | DB02362 | |
| 0.114 | 0.105 | 0.129 | Neurotrophic factor | 0.129 0.082 DB02362 0.123 0.091 DBMET03290 | DB02362 | |
| 0.041 | 0.032 | 0.085 | Nerve growth factor antagonist | 0.085 0.004 DB02362 0.068 0.006 DBMET03290 | DB02362 | |
| 0.161 | 0.152 | 0.186 | Antioxidant | 0.186 0.126 DB02362 | DB02362 | |
| 0.166 | 0.157 | 0.185 | Streptokinase A inhibitor | 0.185 0.143 DBMET03291 0.179 0.147 DBMET03290 | DBMET03291 | |
| 0.03 | 0.022 | 0.039 | Lysophosphatidic acid 2 receptor antagonist | 0.039 0.013 DB02362 0.039 0.013 DBMET03290 | DBMET03290 | |
| 0.109 | 0.101 | 0.145 | Antibacterial (Helicobacter pylori) | 0.145 0.051 DBMET03291 0.131 0.067 DBMET03290 | DBMET03291 | |
| 0.027 | 0.02 | 0.047 | Uridine phosphorylase inhibitor | 0.047 0.009 DB02362 0.032 0.016 DBMET03290 | DB02362 | |
| 0.059 | 0.052 | 0.08 | Histone deacetylase SIRT3 inhibitor | 0.08 0.018 DBMET03291 0.071 0.027 DBMET03290 | DBMET03291 | |
| 0.066 | 0.059 | 0.107 | Epoxide hydrolase inhibitor | 0.064 0.063 DB02362 0.107 0.021 DBMET03291 0.103 0.023 DBMET03290 | DBMET03291 | |
| 0.068 | 0.061 | 0.078 | CDC25A inhibitor | 0.078 0.046 DB02362 | DB02362 | |
| 0.081 | 0.074 | 0.115 | Potassium channel activator | 0.084 0.069 DB02362 0.106 0.042 DBMET03291 0.115 0.036 DBMET03290 | DBMET03290 | |
| 0.024 | 0.017 | 0.024 | 5 Hydroxytryptamine 4 agonist | |||
| 0.033 | 0.027 | 0.09 | Kainate receptor 2 antagonist | 0.09 0.005 DB02362 0.057 0.013 DBMET03290 | DB02362 | |
| 0.033 | 0.026 | 0.066 | RNA-directed RNA polymerase inhibitor | 0.066 0.008 DB02362 0.052 0.012 DBMET03290 | DB02362 | |
| 0.029 | 0.023 | 0.029 | Acetylcholine M4 receptor agonist | |||
| 0.033 | 0.027 | 0.077 | Phosphoglycerate kinase inhibitor | 0.077 0.009 DB02362 0.041 0.018 DBMET03290 | DB02362 | |
| 0.027 | 0.022 | 0.104 | AMPA 1 receptor antagonist | 0.104 0.005 DB02362 0.051 0.011 DBMET03290 | DB02362 | |
| 0.091 | 0.086 | 0.103 | Beta glucuronidase inhibitor | 0.103 0.065 DB02362 0.097 0.075 DBMET03291 0.102 0.066 DBMET03290 | DB02362 | |
| 0.039 | 0.034 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 DB02362 0.04 0.033 DBMET03290 | DB02362 | |
| 0.02 | 0.015 | 0.033 | Retinoid X beta receptor antagonist | 0.033 0.004 DB02362 0.02 0.015 DBMET03292 0.026 0.006 DBMET03290 | DB02362 | |
| 0.023 | 0.018 | 0.106 | NMDA receptor glycine site antagonist | 0.078 0.004 DB02362 0.034 0.01 DBMET03291 0.106 0.004 DBMET03290 | DBMET03290 | |
| 0.021 | 0.017 | 0.021 | Purinergic P2Y12 antagonist | |||
| 0.022 | 0.018 | 0.083 | Retinoid X gamma receptor agonist | 0.083 0.004 DB02362 0.047 0.006 DBMET03290 | DB02362 | |
| 0.022 | 0.018 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DB02362 | ||
| 0.039 | 0.035 | 0.072 | Kainate receptor agonist | 0.072 0.004 DB02362 0.053 0.011 DBMET03290 | DB02362 | |
| 0.06 | 0.057 | 0.085 | Beta 3 adrenoreceptor antagonist | 0.07 0.034 DB02362 0.069 0.035 DBMET03291 0.085 0.02 DBMET03290 | DBMET03290 | |
| 0.012 | 0.01 | 0.087 | Human herpes virus 5 capsid protein P40 inhibitor | 0.017 0.005 DB02362 0.019 0.004 DBMET03291 0.087 0.002 DBMET03292 0.029 0.004 DBMET03290 | DBMET03292 | |
| 0.065 | 0.063 | 0.065 | Acetylcholine M4 receptor antagonist | |||
| 0.015 | 0.014 | 0.015 | CDK2/cyclin A3 inhibitor | |||
| 0.027 | 0.026 | 0.105 | Purinergic P2Y14 antagonist | 0.105 0.004 DB02362 0.036 0.014 DBMET03291 0.102 0.004 DBMET03290 | DB02362 | |
| 0.019 | 0.017 | 0.076 | Retinoid X beta receptor agonist | 0.076 0.004 DB02362 0.04 0.006 DBMET03290 | DB02362 | |
| 0.057 | 0.056 | 0.065 | Trypsin inhibitor | 0.065 0.038 DB02362 | DB02362 | |
| 0.012 | 0.011 | 0.034 | Carbonic anhydrase XI inhibitor | 0.017 0.005 DB02362 0.025 0.003 DBMET03291 0.034 0.003 DBMET03290 | DBMET03290 | |
| 0.14 | 0.139 | 0.24 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.24 0.072 DB02362 | DB02362 | |
| 0.033 | 0.032 | 0.048 | Farnesoid X receptor agonist | 0.048 0.016 DB02362 0.048 0.016 DBMET03290 | DBMET03290 | |
| 0.096 | 0.095 | 0.137 | Beta amyloid protein antagonist | 0.137 0.051 DB02362 | DB02362 | |
| 0.017 | 0.017 | 0.021 | Estrogen-related receptor gamma agonist | 0.021 0.009 DB02362 0.018 0.015 DBMET03290 | DB02362 | |
| 0.03 | 0.031 | 0.074 | Arginase inhibitor | 0.074 0.007 DB02362 0.049 0.016 DBMET03290 | DB02362 | |
| 0.08 | 0.081 | 0.207 | 5-Lipoxygenase inhibitor | 0.207 0.023 DBMET03292 | DBMET03292 | |
| 0.061 | 0.062 | 0.109 | Glutamate (mGluR7) antagonist | 0.109 0.007 DB02362 0.077 0.031 DBMET03290 | DB02362 | |
| 0.118 | 0.119 | 0.166 | NOS3 expression enhancer | 0.138 0.086 DB02362 0.147 0.076 DBMET03291 0.166 0.059 DBMET03290 | DBMET03290 | |
| 0.013 | 0.015 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 DB02362 | DB02362 | |
| 0.026 | 0.028 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.015 DB02362 0.027 0.025 DBMET03290 | DB02362 | |
| 0.053 | 0.056 | 0.063 | Cyclin D1 inhibitor | 0.063 0.038 DB02362 0.06 0.043 DBMET03290 | DB02362 | |
| 0.026 | 0.029 | 0.055 | HCV NS5B polymerase inhibitor | 0.055 0.009 DB02362 0.04 0.014 DBMET03290 | DB02362 | |
| 0.055 | 0.058 | 0.089 | Leukotriene antagonist | 0.089 0.027 DB02362 0.074 0.036 DBMET03290 | DB02362 | |
| 0.03 | 0.033 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.021 DBMET03291 | DBMET03291 | |
| 0.029 | 0.033 | 0.079 | Leukotriene A4 hydrolase inhibitor | 0.079 0.009 DB02362 0.043 0.024 DBMET03291 0.073 0.01 DBMET03290 | DB02362 | |
| 0.022 | 0.026 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 DB02362 0.027 0.015 DBMET03290 | DB02362 | |
| 0.018 | 0.024 | 0.02 | Factor XIII inhibitor | 0.02 0.016 DBMET03291 | DBMET03291 | |
| 0.022 | 0.029 | 0.024 | Complement factor 1r inhibitor | 0.024 0.022 DB02362 | DB02362 | |
| 0.021 | 0.027 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 DB02362 0.028 0.013 DBMET03290 | DBMET03290 | |
| 0.009 | 0.015 | 0.038 | Glutamate (mGluR6) agonist | 0.038 0.003 DB02362 0.017 0.005 DBMET03290 | DB02362 | |
| 0.009 | 0.016 | 0.021 | Angiotensin AT1B receptor antagonist | 0.018 0.007 DB02362 0.021 0.005 DBMET03290 | DBMET03290 | |
| 0.035 | 0.042 | 0.053 | Leukotriene C4 antagonist | 0.045 0.015 DB02362 0.039 0.026 DBMET03291 0.053 0.008 DBMET03290 | DBMET03290 | |
| 0.012 | 0.019 | 0.023 | Ileal bile acid transport inhibitor | 0.015 0.014 DB02362 0.023 0.007 DBMET03292 | DBMET03292 | |
| 0.023 | 0.03 | 0.029 | Complement factor 1s inhibitor | 0.029 0.01 DB02362 | DB02362 | |
| 0.033 | 0.04 | 0.079 | GABA uptake inhibitor | 0.079 0.005 DB02362 0.049 0.017 DBMET03290 | DB02362 | |
| 0.051 | 0.059 | 0.067 | Heat shock protein 90 beta antagonist | 0.067 0.031 DB02362 | DB02362 | |
| 0.069 | 0.076 | 0.099 | Sphingosine 1-phosphate receptor antagonist | 0.075 0.058 DB02362 0.085 0.036 DBMET03291 0.099 0.022 DBMET03290 | DBMET03290 | |
| 0.025 | 0.034 | 0.032 | Cholesterol ester transfer protein antagonist | 0.032 0.021 DBMET03291 0.032 0.021 DBMET03290 | DBMET03290 | |
| 0.082 | 0.091 | 0.201 | Falcipain 3 inhibitor | 0.164 0.03 DB02362 0.123 0.052 DBMET03291 0.201 0.017 DBMET03290 | DBMET03290 | |
| 0.03 | 0.039 | 0.044 | Factor VIIa inhibitor | 0.044 0.022 DB02362 | DB02362 | |
| 0.086 | 0.095 | 0.195 | Protein-tyrosine phosphatase 1B inhibitor | 0.195 0.031 DB02362 0.16 0.042 DBMET03290 | DB02362 | |
| 0.014 | 0.023 | 0.06 | Retinoic acid receptor antagonist | 0.06 0.004 DB02362 0.035 0.005 DBMET03290 | DB02362 | |
| 0.036 | 0.046 | 0.068 | Geranyltranstransferase inhibitor | 0.068 0.009 DB02362 0.046 0.028 DBMET03290 | DB02362 | |
| 0.046 | 0.056 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.047 DBMET03291 | DBMET03291 | |
| 0.02 | 0.03 | 0.05 | Lysine carboxypeptidase inhibitor | 0.05 0.008 DB02362 | DB02362 | |
| 0.057 | 0.067 | 0.065 | Beta 2 adrenoreceptor agonist | 0.065 0.03 DB02362 0.064 0.034 DBMET03290 | DB02362 | |
| 0.031 | 0.041 | 0.045 | DNA gyrase subunit B inhibitor | 0.037 0.027 DB02362 0.036 0.029 DBMET03291 0.045 0.017 DBMET03290 | DBMET03290 | |
| 0.027 | 0.038 | 0.064 | Carnitine palmitoyltransferase inhibitor | 0.047 0.01 DB02362 0.045 0.012 DBMET03291 0.064 0.005 DBMET03290 | DBMET03290 | |
| 0.025 | 0.035 | 0.061 | Epoxide hydrolase 1 inhibitor | 0.034 0.017 DB02362 0.045 0.008 DBMET03291 0.061 0.004 DBMET03290 | DBMET03290 | |
| 0.009 | 0.019 | 0.049 | Retinoic acid receptor gamma antagonist | 0.049 0.003 DB02362 0.02 0.004 DBMET03290 | DB02362 | |
| 0.079 | 0.09 | 0.147 | Urease inhibitor | 0.137 0.03 DB02362 0.097 0.071 DBMET03291 0.147 0.025 DBMET03290 | DBMET03290 | |
| 0.036 | 0.047 | 0.082 | Thymidylate synthase inhibitor | 0.082 0.007 DB02362 0.043 0.038 DBMET03290 | DB02362 | |
| 0.021 | 0.033 | 0.055 | Nicotinic acid receptor 2 antagonist | 0.048 0.004 DB02362 0.024 0.023 DBMET03291 0.055 0.003 DBMET03290 | DBMET03290 | |
| 0.004 | 0.016 | 0.015 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DB02362 0.009 0.005 DBMET03290 | DB02362 | |
| 0.056 | 0.069 | 0.07 | Transcription factor RelA inhibitor | 0.07 0.03 DB02362 | DB02362 | |
| 0.033 | 0.045 | 0.145 | AMPA 4 receptor antagonist | 0.145 0.004 DB02362 0.049 0.016 DBMET03290 | DB02362 | |
| 0.123 | 0.135 | 0.224 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.224 0.01 DB02362 0.184 0.029 DBMET03290 | DB02362 | |
| 0.067 | 0.08 | 0.135 | Glycine receptor antagonist | 0.099 0.034 DB02362 0.096 0.036 DBMET03291 0.135 0.011 DBMET03290 | DBMET03290 | |
| 0.035 | 0.048 | 0.046 | Antimetabolite | 0.046 0.034 DB02362 | DB02362 | |
| 0.081 | 0.095 | 0.096 | Interleukin 12 antagonist | 0.096 0.061 DBMET03291 | DBMET03291 | |
| 0.017 | 0.031 | 0.03 | Beta 1 adrenoreceptor agonist | 0.029 0.009 DB02362 0.03 0.008 DBMET03290 | DBMET03290 | |
| 0.015 | 0.03 | 0.019 | Antibiotic Anthracycline-like | 0.019 0.014 DB02362 | DB02362 | |
| 0.027 | 0.041 | 0.061 | Carnitine palmitoyltransferase 1 inhibitor | 0.046 0.01 DB02362 0.042 0.014 DBMET03291 0.061 0.005 DBMET03290 | DBMET03290 | |
| 0.023 | 0.037 | 0.035 | Sirtuin 2 inhibitor | 0.035 0.021 DBMET03291 | DBMET03291 | |
| 0.021 | 0.036 | 0.051 | LFA antagonist | 0.051 0.005 DB02362 | DB02362 | |
| 0.019 | 0.034 | 0.031 | Liver X receptor beta antagonist | 0.031 0.018 DB02362 | DB02362 | |
| 0.043 | 0.058 | 0.073 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.073 0.02 DB02362 0.057 0.033 DBMET03290 | DB02362 | |
| 0.027 | 0.042 | 0.036 | Carboxypeptidase B inhibitor | 0.036 0.017 DB02362 | DB02362 | |
| 0.013 | 0.03 | 0.053 | Retinoic acid alpha receptor antagonist | 0.053 0.004 DB02362 0.037 0.005 DBMET03290 | DB02362 | |
| 0.038 | 0.055 | 0.043 | Cholesterol esterase inhibitor | 0.043 0.041 DBMET03291 | DBMET03291 | |
| 0.082 | 0.099 | 0.316 | Protein kinase (CK2) alpha inhibitor | 0.244 0.017 DB02362 0.123 0.06 DBMET03291 0.316 0.01 DBMET03290 | DBMET03290 | |
| 0.027 | 0.044 | 0.075 | Glutamate (mGluR4) agonist | 0.075 0.006 DB02362 0.039 0.016 DBMET03290 | DB02362 | |
| 0.14 | 0.158 | 0.182 | Free radical scavenger | 0.182 0.113 DB02362 | DB02362 | |
| 0.057 | 0.075 | 0.076 | Na+ K+ transporting ATPase inhibitor | 0.076 0.054 DB02362 | DB02362 | |
| 0.025 | 0.043 | 0.076 | 5-Alpha-reductase inhibitor | 0.06 0.016 DB02362 0.076 0.013 DBMET03290 | DBMET03290 | |
| 0.028 | 0.047 | 0.051 | Glutamate (mGluR group II) antagonist | 0.051 0.015 DB02362 | DB02362 | |
| 0.027 | 0.046 | 0.057 | Diamine oxidase inhibitor | 0.044 0.019 DB02362 0.038 0.026 DBMET03291 0.057 0.011 DBMET03290 | DBMET03290 | |
| 0.005 | 0.024 | 0.01 | Beta 3 adrenoreceptor agonist | 0.01 0.009 DBMET03290 | DBMET03290 | |
| 0.01 | 0.03 | 0.015 | Adenosine A2 receptor agonist | 0.015 0.013 DB02362 0.015 0.013 DBMET03290 | DBMET03290 | |
| 0.169 | 0.189 | 0.38 | Transcription factor STAT inhibitor | 0.234 0.098 DB02362 0.3 0.056 DBMET03291 0.38 0.024 DBMET03290 | DBMET03290 | |
| 0.055 | 0.074 | 0.203 | Potassium channel large-conductance Ca-activated activator | 0.203 0.006 DB02362 0.083 0.033 DBMET03290 | DB02362 | |
| 0.043 | 0.062 | 0.087 | Factor III inhibitor | 0.087 0.006 DB02362 0.068 0.012 DBMET03290 | DB02362 | |
| 0.032 | 0.051 | 0.151 | NMDA receptor subunit 3B antagonist | 0.151 0.006 DB02362 0.081 0.013 DBMET03290 | DB02362 | |
| 0.015 | 0.035 | 0.042 | Glutamate (mGluR1a) agonist | 0.042 0.005 DB02362 0.025 0.012 DBMET03290 | DB02362 | |
| 0.134 | 0.154 | 0.236 | Dyrk kinase inhibitor | 0.236 0.079 DB02362 | DB02362 | |
| 0.015 | 0.035 | 0.029 | Lysophosphatidic acid 1 receptor antagonist | 0.029 0.007 DB02362 0.024 0.01 DBMET03290 | DB02362 | |
| 0.018 | 0.038 | 0.024 | ICAM 1 antagonist | 0.024 0.014 DB02362 | DB02362 | |
| 0.046 | 0.066 | 0.057 | Botulinum neurotoxin type A inhibitor | 0.057 0.042 DB02362 0.056 0.045 DBMET03290 | DB02362 | |
| 0.017 | 0.038 | 0.077 | AMPA 3 receptor antagonist | 0.077 0.005 DB02362 0.042 0.013 DBMET03290 | DB02362 | |
| 0.013 | 0.034 | 0.065 | 5-Alpha-reductase 2 inhibitor | 0.035 0.008 DB02362 0.065 0.006 DBMET03290 | DBMET03290 | |
| 0.022 | 0.043 | 0.031 | Glutamate (mGluR2) antagonist | 0.031 0.019 DB02362 | DB02362 | |
| 0.073 | 0.095 | 0.1 | 3C-Like protease (SARS coronavirus) inhibitor | 0.094 0.039 DBMET03291 0.1 0.033 DBMET03290 | DBMET03290 | |
| 0.123 | 0.145 | 0.268 | Interleukin antagonist | 0.14 0.126 DB02362 0.243 0.064 DBMET03291 0.268 0.055 DBMET03290 | DBMET03290 | |
| 0.032 | 0.054 | 0.135 | Glutamate (mGluR group III) agonist | 0.135 0.005 DB02362 0.094 0.011 DBMET03290 | DB02362 | |
| 0.051 | 0.074 | 0.192 | NMDA 2 receptor antagonist | 0.192 0.01 DB02362 0.1 0.032 DBMET03290 | DB02362 | |
| 0.072 | 0.094 | 0.255 | Protein kinase (CK2) inhibitor | 0.233 0.013 DB02362 0.095 0.068 DBMET03291 0.255 0.01 DBMET03290 | DBMET03290 | |
| 0.009 | 0.031 | 0.066 | 5-Alpha-reductase 1 inhibitor | 0.027 0.009 DB02362 0.066 0.006 DBMET03290 | DBMET03290 | |
| 0.006 | 0.029 | 0.044 | Retinoic acid beta receptor antagonist | 0.044 0.003 DB02362 0.021 0.004 DBMET03290 | DB02362 | |
| 0.021 | 0.044 | 0.038 | Retinoid X gamma receptor antagonist | 0.038 0.005 DB02362 0.032 0.009 DBMET03290 | DB02362 | |
| 0.009 | 0.032 | 0.062 | Kainate receptor 1 antagonist | 0.062 0.005 DB02362 0.04 0.007 DBMET03290 | DB02362 | |
| 0.004 | 0.028 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 DB02362 | DB02362 | |
| 0.028 | 0.054 | 0.05 | Dopamine D5 agonist | 0.05 0.017 DB02362 | DB02362 | |
| 0.027 | 0.054 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.015 DB02362 0.033 0.026 DBMET03290 | DB02362 | |
| 0.028 | 0.055 | 0.063 | Glutamate (mGluR8) antagonist | 0.063 0.005 DB02362 0.04 0.016 DBMET03290 | DB02362 | |
| 0.011 | 0.038 | 0.026 | Prostaglandin EP2 agonist | 0.026 0.014 DB02362 | DB02362 | |
| 0.026 | 0.053 | 0.086 | Urate transporter 1 inhibitor | 0.086 0.007 DB02362 0.066 0.012 DBMET03290 | DB02362 | |
| 0.038 | 0.065 | 0.049 | Potassium channel (ATP-sensitive) activator | 0.049 0.031 DBMET03291 0.049 0.031 DBMET03290 | DBMET03290 | |
| 0.039 | 0.067 | 0.052 | Potassium channel (Inward rectifier) activator | 0.052 0.033 DBMET03291 0.052 0.032 DBMET03290 | DBMET03290 | |
| 0.023 | 0.052 | 0.127 | Nicotinic acid receptor 2 agonist | 0.124 0.005 DB02362 0.034 0.027 DBMET03291 0.127 0.005 DBMET03290 | DBMET03290 | |
| 0.086 | 0.115 | 0.106 | CDC-like kinase 3 inhibitor | 0.106 0.067 DBMET03291 0.103 0.073 DBMET03290 | DBMET03291 | |
| 0.057 | 0.086 | 0.086 | Phospholipase D inhibitor | 0.086 0.027 DB02362 0.066 0.062 DBMET03290 | DB02362 | |
| 0.027 | 0.056 | 0.055 | Urokinase inhibitor | 0.055 0.03 DB02362 | DB02362 | |
| 0.134 | 0.163 | 0.163 | Platelet antagonist | 0.163 0.132 DB02362 0.148 0.147 DBMET03290 | DB02362 | |
| 0.006 | 0.036 | 0.019 | Thrombopoietin agonist | 0.016 0.005 DB02362 0.019 0.004 DBMET03290 | DBMET03290 | |
| 0.026 | 0.056 | 0.072 | Protein kinase (CK2) beta inhibitor | 0.072 0.004 DB02362 0.052 0.007 DBMET03290 | DB02362 | |
| 0.022 | 0.053 | 0.032 | Free fatty acid receptor 1 antagonist | 0.032 0.026 DB02362 | DB02362 | |
| 0.024 | 0.055 | 0.048 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.016 DB02362 0.048 0.01 DBMET03290 | DBMET03290 | |
| 0.052 | 0.084 | 0.085 | Protein kinase C beta inhibitor | 0.085 0.024 DB02362 0.067 0.054 DBMET03290 | DB02362 | |
| 0.015 | 0.048 | 0.035 | Factor VII inhibitor | 0.035 0.017 DB02362 | DB02362 | |
| 0.031 | 0.063 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DBMET03290 | DBMET03290 | |
| 0.002 | 0.035 | 0.007 | Insulin like growth factor 3 antagonist | 0.007 0.004 DB02362 | DB02362 | |
| 0.013 | 0.046 | 0.021 | Caspase 8 inhibitor | 0.019 0.016 DBMET03291 0.021 0.011 DBMET03290 | DBMET03290 | |
| 0.036 | 0.07 | 0.041 | Heme oxygenase inhibitor | 0.041 0.037 DB02362 | DB02362 | |
| 0.017 | 0.051 | 0.031 | Thyroid hormone agonist | 0.027 0.017 DBMET03291 0.031 0.011 DBMET03290 | DBMET03290 | |
| 0.03 | 0.065 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | 0.05 0.041 DB02362 0.046 0.044 DBMET03290 | DB02362 | |
| 0.03 | 0.065 | 0.051 | Ribonucleotide reductase inhibitor | 0.051 0.042 DB02362 | DB02362 | |
| 0.007 | 0.043 | 0.02 | Aminopeptidase A inhibitor | 0.02 0.01 DB02362 0.016 0.015 DBMET03290 | DB02362 | |
| 0.012 | 0.048 | 0.051 | Somatostatin 5 antagonist | 0.051 0.013 DB02362 | DB02362 | |
| 0.036 | 0.074 | 0.099 | Factor IXa inhibitor | 0.098 0.01 DB02362 0.048 0.041 DBMET03291 0.099 0.01 DBMET03290 | DBMET03290 | |
| 0.18 | 0.218 | 0.26 | Immunosuppressant | 0.26 0.14 DB02362 0.208 0.188 DBMET03290 | DB02362 | |
| 0.04 | 0.078 | 0.052 | Sphingosine kinase 2 inhibitor | 0.052 0.043 DB02362 | DB02362 | |
| 0.069 | 0.106 | 0.086 | mTOR complex 2 inhibitor | 0.086 0.054 DB02362 | DB02362 | |
| 0.132 | 0.171 | 0.261 | Antiamyloidogenic | 0.261 0.066 DB02362 0.178 0.116 DBMET03290 | DB02362 | |
| 0.021 | 0.06 | 0.063 | TRPM8 blocker | 0.062 0.011 DB02362 0.063 0.011 DBMET03290 | DBMET03290 | |
| 0.025 | 0.065 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.028 DBMET03291 | DBMET03291 | |
| 0.009 | 0.05 | 0.046 | Nicotinic acid receptor 1 antagonist | 0.039 0.003 DB02362 0.046 0.003 DBMET03290 | DBMET03290 | |
| 0.016 | 0.058 | 0.03 | Prostaglandin agonist | 0.03 0.023 DB02362 | DB02362 | |
| 0.037 | 0.08 | 0.106 | Purinergic P2X2 antagonist | 0.106 0.027 DB02362 | DB02362 | |
| 0.01 | 0.053 | 0.021 | Angiotensin AT1A receptor antagonist | 0.021 0.018 DB02362 | DB02362 | |
| 0.013 | 0.056 | 0.046 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 DB02362 0.021 0.018 DBMET03291 0.046 0.005 DBMET03290 | DBMET03290 | |
| 0.071 | 0.115 | 0.08 | T cell inhibitor | 0.08 0.067 DB02362 | DB02362 | |
| 0.067 | 0.111 | 0.09 | Thioredoxin reductase inhibitor | 0.09 0.041 DB02362 0.078 0.068 DBMET03290 | DB02362 | |
| 0.01 | 0.054 | 0.021 | Prostaglandin E2 agonist | 0.021 0.019 DB02362 | DB02362 | |
| 0.028 | 0.073 | 0.039 | Thymidine kinase inhibitor | 0.039 0.032 DB02362 | DB02362 | |
| 0.012 | 0.057 | 0.038 | Leukotriene B4 receptor 1 antagonist | 0.038 0.013 DB02362 | DB02362 | |
| 0.008 | 0.055 | 0.014 | Thromboxane A2 agonist | 0.014 0.013 DBMET03290 | DBMET03290 | |
| 0.035 | 0.083 | 0.07 | Protein kinase C eta inhibitor | 0.07 0.029 DB02362 | DB02362 | |
| 0.102 | 0.149 | 0.15 | Insulin secretagoues | 0.15 0.075 DB02362 | DB02362 | |
| 0.045 | 0.093 | 0.069 | I kappa B kinase 2 inhibitor | 0.069 0.034 DB02362 | DB02362 | |
| 0.065 | 0.113 | 0.098 | Prolactin inhibitor | 0.098 0.057 DB02362 0.082 0.079 DBMET03290 | DB02362 | |
| 0.076 | 0.125 | 0.098 | Proteasome inhibitor | 0.098 0.091 DBMET03291 0.096 0.094 DBMET03290 | DBMET03291 | |
| 0.035 | 0.083 | 0.06 | Dopamine beta hydroxylase inhibitor | 0.06 0.015 DB02362 | DB02362 | |
| 0.054 | 0.105 | 0.088 | Bcr-Abl kinase inhibitor | 0.077 0.068 DB02362 0.088 0.053 DBMET03290 | DBMET03290 | |
| 0.116 | 0.167 | 0.165 | MAP kinase kinase 4 inhibitor | 0.165 0.039 DB02362 | DB02362 | |
| 0.042 | 0.094 | 0.058 | Sphingosine kinase inhibitor | 0.055 0.05 DB02362 0.058 0.042 DBMET03290 | DBMET03290 | |
| 0.025 | 0.078 | 0.068 | Nicotinic acid receptor 1 agonist | 0.061 0.016 DB02362 0.068 0.014 DBMET03290 | DBMET03290 | |
| 0.147 | 0.202 | 0.287 | Peptidyltransferase inhibitor | 0.217 0.079 DB02362 0.233 0.064 DBMET03291 0.287 0.03 DBMET03290 | DBMET03290 | |
| 0.018 | 0.074 | 0.034 | ATP citrate lysase inhibitor | 0.034 0.019 DB02362 | DB02362 | |
| 0.057 | 0.114 | 0.098 | Cell adhesion molecule inhibitor | 0.098 0.036 DB02362 0.078 0.055 DBMET03290 | DB02362 | |
| 0.041 | 0.101 | 0.101 | Prostaglandin-E synthase inhibitor | 0.072 0.046 DBMET03291 0.101 0.026 DBMET03290 | DBMET03290 | |
| 0.031 | 0.092 | 0.039 | CF transmembrane conductance regulator antagonist | 0.039 0.029 DB02362 | DB02362 | |
| 0.023 | 0.085 | 0.056 | Thromboxane A2 antagonist | 0.056 0.031 DB02362 0.05 0.036 DBMET03290 | DB02362 | |
| 0.014 | 0.077 | 0.091 | NMDA 2D receptor antagonist | 0.091 0.004 DB02362 0.06 0.005 DBMET03290 | DB02362 | |
| 0.109 | 0.172 | 0.141 | MAP kinase 3 inhibitor | 0.129 0.108 DB02362 0.141 0.083 DBMET03292 0.128 0.113 DBMET03290 | DBMET03292 | |
| 0.04 | 0.102 | 0.063 | Sphingosine 1-phosphate receptor 1 antagonist | 0.063 0.024 DBMET03290 | DBMET03290 | |
| 0.039 | 0.101 | 0.061 | Leukotriene synthesis inhibitor | 0.061 0.054 DB02362 | DB02362 | |
| 0.034 | 0.097 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.041 DBMET03290 | DBMET03290 | |
| 0.061 | 0.125 | 0.085 | Aminoacyl-tRNA synthetase inhibitor | 0.085 0.068 DB02362 | DB02362 | |
| 0.068 | 0.133 | 0.118 | Chelator | 0.118 0.055 DB02362 0.106 0.069 DBMET03290 | DB02362 | |
| 0.017 | 0.083 | 0.024 | Thymidine phosphorylase inhibitor | 0.024 0.023 DB02362 | DB02362 | |
| 0.087 | 0.155 | 0.126 | Transcription factor STAT6 inhibitor | 0.117 0.066 DB02362 0.126 0.05 DBMET03290 | DBMET03290 | |
| 0.025 | 0.093 | 0.058 | Thromboxane antagonist | 0.058 0.034 DB02362 0.052 0.039 DBMET03290 | DB02362 | |
| 0.028 | 0.097 | 0.058 | Guanylate cyclase stimulant | 0.058 0.015 DB02362 | DB02362 | |
| 0.049 | 0.118 | 0.093 | Androgen antagonist | 0.074 0.073 DBMET03291 0.093 0.052 DBMET03290 | DBMET03290 | |
| 0.047 | 0.117 | 0.069 | Secretase beta inhibitor | 0.069 0.052 DB02362 0.067 0.055 DBMET03290 | DB02362 | |
| 0.073 | 0.143 | 0.138 | Cyclooxygenase 1 inhibitor | 0.138 0.064 DB02362 | DB02362 | |
| 0.006 | 0.078 | 0.033 | Prostaglandin H2 antagonist | 0.033 0.01 DB02362 | DB02362 | |
| 0.008 | 0.08 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.013 DB02362 | DB02362 | |
| 0.069 | 0.144 | 0.155 | AMP-activated protein kinase stimulant | 0.155 0.025 DB02362 0.142 0.033 DBMET03290 | DB02362 | |
| 0.034 | 0.111 | 0.061 | Collagenase 3 inhibitor | 0.061 0.04 DBMET03292 | DBMET03292 | |
| 0.041 | 0.119 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 DBMET03290 | DBMET03290 | |
| 0.095 | 0.173 | 0.13 | Cyclin-dependent kinase 8 inhibitor | 0.13 0.103 DB02362 | DB02362 | |
| 0.075 | 0.156 | 0.134 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.134 0.089 DB02362 | DB02362 | |
| 0.03 | 0.111 | 0.052 | Lysine-specific demethylase 1A inhibitor | 0.052 0.041 DB02362 | DB02362 | |
| 0.049 | 0.13 | 0.093 | I kappa B kinase inhibitor | 0.093 0.045 DB02362 | DB02362 | |
| 0.02 | 0.102 | 0.064 | Factor XIa inhibitor | 0.058 0.013 DB02362 0.064 0.011 DBMET03290 | DBMET03290 | |
| 0.017 | 0.1 | 0.045 | Factor XI inhibitor | 0.042 0.014 DB02362 0.045 0.012 DBMET03290 | DBMET03290 | |
| 0.032 | 0.116 | 0.06 | Carbonic anhydrase stimulant | 0.06 0.041 DB02362 0.056 0.045 DBMET03290 | DB02362 | |
| 0.011 | 0.094 | 0.028 | Prostaglandin EP4 antagonist | 0.024 0.02 DB02362 0.028 0.017 DBMET03290 | DBMET03290 | |
| 0.029 | 0.112 | 0.094 | Selectin antagonist | 0.059 0.051 DB02362 0.055 0.054 DBMET03291 0.094 0.03 DBMET03290 | DBMET03290 | |
| 0.028 | 0.112 | 0.055 | DNA gyrase subunit A inhibitor | 0.055 0.013 DB02362 0.041 0.034 DBMET03290 | DB02362 | |
| 0.104 | 0.19 | 0.129 | Pregnane X receptor agonist | 0.129 0.102 DBMET03291 0.127 0.107 DBMET03290 | DBMET03291 | |
| 0.034 | 0.122 | 0.104 | HIV-1 integrase (3'-Processing) inhibitor | 0.104 0.025 DB02362 0.084 0.032 DBMET03290 | DB02362 | |
| 0.022 | 0.11 | 0.04 | Sphingosine 1-phosphate receptor agonist | 0.04 0.038 DB02362 | DB02362 | |
| 0.061 | 0.15 | 0.105 | 5 Hydroxytryptamine 3A agonist | 0.105 0.07 DB02362 | DB02362 | |
| 0.065 | 0.154 | 0.14 | Histone deacetylase class III inhibitor | 0.128 0.062 DBMET03291 0.14 0.052 DBMET03290 | DBMET03290 | |
| 0.035 | 0.128 | 0.131 | Glutamate receptor agonist | 0.131 0.023 DB02362 0.085 0.049 DBMET03290 | DB02362 | |
| 0.026 | 0.122 | 0.089 | HIV-1 integrase (Strand Transfer) inhibitor | 0.089 0.027 DB02362 0.064 0.039 DBMET03290 | DB02362 | |
| 0.071 | 0.168 | 0.136 | Folate antagonist | 0.136 0.028 DB02362 | DB02362 | |
| 0.036 | 0.133 | 0.08 | DNA gyrase inhibitor | 0.08 0.027 DB02362 0.071 0.034 DBMET03290 | DB02362 | |
| 0.01 | 0.111 | 0.034 | Carnitine palmitoyltransferase 1A inhibitor | 0.029 0.019 DB02362 0.034 0.014 DBMET03290 | DBMET03290 | |
| 0.009 | 0.11 | 0.053 | AMPA 2 receptor antagonist | 0.053 0.01 DB02362 | DB02362 | |
| 0.06 | 0.163 | 0.118 | Glycogen synthase kinase-3 alpha inhibitor | 0.118 0.086 DB02362 | DB02362 | |
| 0.031 | 0.134 | 0.084 | Autotaxin inhibitor | 0.084 0.017 DB02362 0.07 0.023 DBMET03290 | DB02362 | |
| 0.007 | 0.111 | 0.041 | Kainate receptor 5 antagonist | 0.041 0.007 DB02362 0.025 0.012 DBMET03290 | DB02362 | |
| 0.036 | 0.14 | 0.079 | Histone deacetylase SIRT2 inhibitor | 0.079 0.046 DBMET03291 | DBMET03291 | |
| 0.073 | 0.178 | 0.132 | Cell adhesion inhibitor | 0.132 0.057 DB02362 0.115 0.07 DBMET03290 | DB02362 | |
| 0.026 | 0.132 | 0.059 | Aminopeptidase microsomal inhibitor | 0.059 0.041 DBMET03292 | DBMET03292 | |
| 0.153 | 0.263 | 0.33 | Sodium/bile acid cotransporter inhibitor | 0.313 0.068 DB02362 0.33 0.054 DBMET03290 | DBMET03290 | |
| 0.017 | 0.127 | 0.042 | Aminopeptidase N inhibitor | 0.042 0.04 DBMET03292 | DBMET03292 | |
| 0.057 | 0.169 | 0.082 | Polo-like kinase-1 inhibitor | 0.082 0.08 DB02362 | DB02362 | |
| 0.059 | 0.175 | 0.166 | Glutamate receptor antagonist | 0.166 0.041 DB02362 | DB02362 | |
| 0.067 | 0.183 | 0.164 | Thrombolytic | 0.164 0.072 DB02362 0.129 0.1 DBMET03290 | DB02362 | |
| 0.061 | 0.178 | 0.099 | Hematopoietic | 0.098 0.038 DB02362 0.099 0.036 DBMET03290 | DBMET03290 | |
| 0.013 | 0.133 | 0.053 | Glutamate (mGluR group II) agonist | 0.053 0.014 DB02362 | DB02362 | |
| 0.046 | 0.167 | 0.059 | Prolactin release inhibitor | 0.059 0.055 DB02362 | DB02362 | |
| 0.013 | 0.137 | 0.028 | Cyclophilin A inhibitor | 0.028 0.027 DBMET03290 | DBMET03290 | |
| 0.01 | 0.135 | 0.045 | Glutamate (mGluR2) agonist | 0.045 0.016 DB02362 | DB02362 | |
| 0.003 | 0.131 | 0.013 | Egl nine homolog 3 inhibitor | 0.013 0.007 DB02362 | DB02362 | |
| 0.01 | 0.139 | 0.039 | Histone deacetylase 2 inhibitor | 0.039 0.019 DBMET03292 | DBMET03292 | |
| 0.024 | 0.154 | 0.054 | Purinergic P2X4 antagonist | 0.054 0.02 DBMET03290 | DBMET03290 | |
| 0.025 | 0.156 | 0.047 | HCV NS3/NS4A protease inhibitor | 0.047 0.039 DBMET03290 | DBMET03290 | |
| 0.019 | 0.151 | 0.038 | Acid-sensing ion channel blocker | 0.038 0.031 DB02362 | DB02362 | |
| 0.007 | 0.14 | 0.023 | Histone deacetylase 1 inhibitor | 0.023 0.018 DBMET03292 | DBMET03292 | |
| 0.004 | 0.137 | 0.039 | Prostaglandin EP1 antagonist | 0.039 0.008 DB02362 0.021 0.013 DBMET03290 | DB02362 | |
| 0.092 | 0.227 | 0.149 | Hypolipemic | 0.149 0.138 DBMET03290 | DBMET03290 | |
| 0.047 | 0.185 | 0.158 | Topoisomerase II inhibitor | 0.158 0.046 DB02362 0.096 0.09 DBMET03290 | DB02362 | |
| 0.084 | 0.222 | 0.127 | Polo-like kinase-3 inhibitor | 0.127 0.114 DB02362 | DB02362 | |
| 0.021 | 0.161 | 0.049 | CC chemokine 2 receptor antagonist | 0.049 0.048 DB02362 | DB02362 | |
| 0.007 | 0.148 | 0.022 | Kainate receptor 4 antagonist | 0.022 0.021 DB02362 | DB02362 | |
| 0.018 | 0.165 | 0.104 | Plasminogen activator inhibitor antagonist | 0.104 0.009 DB02362 0.076 0.016 DBMET03290 | DB02362 | |
| 0.09 | 0.239 | 0.157 | Death-associated protein kinase 3 inhibitor | 0.157 0.111 DB02362 | DB02362 | |
| 0.067 | 0.225 | 0.119 | Anticoagulant | 0.119 0.114 DB02362 | DB02362 | |
| 0.058 | 0.219 | 0.078 | CC chemokine 5 receptor agonist | 0.078 0.074 DBMET03290 | DBMET03290 | |
| 0.021 | 0.185 | 0.069 | Carnitine palmitoyltransferase 1B inhibitor | 0.069 0.012 DB02362 0.065 0.014 DBMET03290 | DB02362 | |
| 0.08 | 0.272 | 0.165 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.165 0.099 DB02362 | DB02362 | |
| 0.012 | 0.207 | 0.112 | Prostaglandin E2 antagonist | 0.112 0.013 DB02362 0.098 0.015 DBMET03290 | DB02362 | |
| 0.082 | 0.281 | 0.237 | Tumour necrosis factor alpha release inhibitor | 0.237 0.081 DBMET03292 | DBMET03292 | |
| 0.039 | 0.244 | 0.193 | Uric acid excretion stimulant | 0.193 0.014 DB02362 0.147 0.024 DBMET03290 | DB02362 | |
| 0.098 | 0.303 | 0.164 | Growth factor agonist | 0.148 0.146 DBMET03291 0.164 0.113 DBMET03290 | DBMET03290 | |
| 0.031 | 0.239 | 0.096 | Pim-1 kinase inhibitor | 0.096 0.062 DB02362 | DB02362 | |
| 0.099 | 0.319 | 0.169 | Cyclin-dependent kinase 3 inhibitor | 0.169 0.062 DBMET03291 0.162 0.072 DBMET03290 | DBMET03291 | |
| 0.01 | 0.258 | 0.05 | Collagenase inhibitor | 0.05 0.032 DBMET03292 | DBMET03292 | |
| 0.14 | 0.416 | 0.282 | MAP kinase kinase 6 inhibitor | 0.282 0.154 DB02362 | DB02362 | |
| 0.021 | 0.298 | 0.081 | Prostaglandin F2 alpha antagonist | 0.081 0.021 DB02362 0.073 0.029 DBMET03290 | DB02362 | |
| 0.018 | 0.298 | 0.066 | Nav1.8 sodium channel blocker | 0.066 0.062 DBMET03290 | DBMET03290 | |
| 0.025 | 0.328 | 0.078 | DNA helicase inhibitor | 0.063 0.024 DB02362 0.078 0.012 DBMET03290 | DBMET03290 | |
| 0.014 | 0.319 | 0.075 | Myc inhibitor | 0.05 0.046 DB02362 0.075 0.016 DBMET03290 | DBMET03290 | |
| 0.007 | 0.329 | 0.066 | Prostaglandin EP2 antagonist | 0.066 0.036 DB02362 0.065 0.037 DBMET03290 | DB02362 | |
| 0.005 | 0.347 | 0.032 | Histone deacetylase 10 inhibitor | 0.032 0.019 DBMET03292 | DBMET03292 | |
| 0.006 | 0.397 | 0.055 | Prostaglandin antagonist | 0.055 0.035 DB02362 0.055 0.035 DBMET03290 | DBMET03290 | |
| 0.007 | 0.4 | 0.037 | Histone deacetylase class IV inhibitor | 0.037 0.018 DBMET03292 | DBMET03292 | |
| 0.007 | 0.4 | 0.037 | Histone deacetylase 11 inhibitor | 0.037 0.018 DBMET03292 | DBMET03292 | |
| 0.083 | 0.497 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.044 DB02362 0.132 0.064 DBMET03290 | DB02362 | |
| 0.005 | 0.432 | 0.058 | Histone deacetylase 5 inhibitor | 0.058 0.014 DBMET03292 | DBMET03292 | |
| 0.087 | 0.514 | 0.299 | Cyclophilin D inhibitor | 0.299 0.164 DB02362 | DB02362 | |
| 0.024 | 0.46 | 0.061 | Kallikrein 7 inhibitor | 0.061 0.051 DBMET03290 | DBMET03290 | |
| 0.092 | 0.553 | 0.26 | Antiinflammatory | 0.26 0.255 DB02362 | DB02362 | |
| 0.035 | 0.506 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.103 DBMET03290 | DBMET03290 | |
| 0.004 | 0.52 | 0.043 | Histone deacetylase class IIa inhibitor | 0.043 0.016 DBMET03292 | DBMET03292 | |
| 0.005 | 0.656 | 0.018 | Potassium channel (Inward rectifier) 11 blocker | 0.018 0.013 DBMET03290 | DBMET03290 | |
| 0.042 | 0.705 | 0.203 | Death-associated protein kinase 2 inhibitor | 0.161 0.083 DBMET03291 0.203 0.033 DBMET03290 | DBMET03290 | |
| 0.004 | 0.687 | 0.032 | Histone deacetylase 4 inhibitor | 0.032 0.023 DBMET03292 | DBMET03292 | |
| 0.004 | 0.694 | 0.05 | Histone deacetylase class II inhibitor | 0.05 0.011 DBMET03292 | DBMET03292 | |
| 0.004 | 0.729 | 0.041 | Histone deacetylase class IIb inhibitor | 0.041 0.012 DBMET03292 | DBMET03292 | |
| 0.004 | 0.736 | 0.041 | Histone deacetylase 6 inhibitor | 0.041 0.012 DBMET03292 | DBMET03292 | |
| 0.007 | 0.812 | 0.035 | ADAM10 endopeptidase inhibitor | 0.035 0.021 DBMET03292 | DBMET03292 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |